Huamin Wang, M.D., Ph.D.

Peer-Reviewed Articles

1. Zuo, X, Wang, L, Liu, Y, Wang, H, Hafley, M, Gagea Iurascu, M, Chen, R, Xiong, Y, Pan, S, Shureiqi, I, Bresalier, R, Wei, D. Dysregulated KLF4 expression plays a pivotal role in the pathogenesis of pancreatic intraductal papillary mucinous neoplasms. Gut 74(2):327-329, 2025. e-Pub 2025. PMID: 38969489.
2. DiPeri, TP, Evans, KW, Scott, S, Zheng, X, Varadarajan, K, Kwong, L, Kahle, M, Cao, HS, Tzeng, CW, Vu, T, Kim, S, Su, F, Raso, G, Rizvi, YQ, Zhao, M, Wang, H, Lee, SS, Yap, TA, Rodon Ahnert, J, Javle, M, Meric-Bernstam, F. Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer. Clinical Cancer Research 31(2):387-402, 2025. e-Pub 2025. PMID: 39513959.
3. Yousef, M, Hurd, MW, Yousef, A, Ludmir, EB, Balachandran Pillai, A, Peterson, J, Koay, EJ, Albarouki, S, Tzeng, CW, Snyder, RA, Katz, MH, Wang, H, Overman, MJ, Maitra, A, Pant, S, Smaglo, BG, Wolff, RA, Yao, JC, Shen, JY, Zhao, D. Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. Oncologist 30(17), 2025. e-Pub 2025. PMID: 39014543.
4. Fu, J, Ling, J, Li, CF, Tsai, C, Yin, W, Hou, J, Chen, P, Cao, Y, Kang, Y, Sun, YC, Xia, X, Jiang, Z, Furukawa, K, Lu, Y, Wu, M, Huang, Q, Yao, J, Hawke, DH, Pan, BF, Zhao, J, Huang, J, Wang, H, Bahassi, EI, Stambrook, PJ, Huang, P, Fleming, JB, Maitra, A, Tainer, J, Hung, MC, Lin, C, Chiao, PJ. Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. Nature communications 15(1), 2024. e-Pub 2024. PMID: 38605037.
5. Ma, Y, Zhao, X, Feng, J, Qiu, S, Ji, B, Huang, L, Hwu, P, Logsdon, C, Wang, H. Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancer. iScience 27(11), 2024. e-Pub 2024. PMID: 39473974.
6. Saito, Y, Xiao, Y, Yao, J, Li, Y, Liu, W, Yuzhalin, A, Shyu, YM, Li, H, Yuan, X, Li, P, Zhang, Q, Li, Z, Wei, Y, Yin, X, Zhao, J, Kariminia, SM, Wu, Y, Wang, J, Yang, JX, Xia, W, Sun, Y, Jho, EH, Chiao, PJ, Hwang, RF, Ying, H, Wang, H, Zhao, Z, Maitra, A, Hung, MC, DePinho, RA, Yu, D. Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer. Cell Discovery 10(1), 2024. e-Pub 2024. PMID: 39468013.
7. Taherian, M, Katz, MH, Prakash, L, Wei, D, Tong, YT, Lai, Z, Chatterjee, D, Wang, H, Kim, M, Tzeng, CD, Ikoma, N, Wolff, RA, Zhao, D, Koay, EJ, Maitra, A, Wang, H. The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Cancers (Basel) 16(19), 2024. e-Pub 2024. PMID: 39409932.
8. Janssen, BV, Oteman, B, Ali, M, Valkema, PA, Adsay, V, Basturk, O, Chatterjee, D, Chou, A, Crobach, S, Doukas, M, Drillenburg, P, Esposito, I, Gill, AJ, Hong, SM, Jansen, C, Kliffen, M, Mittal, A, Samra, JS, Van Velthuysen, MF, Yavas, A, Kazemier, G, Verheij, J, Steyerberg, EW, Besselink, MG, Wang, H, Verbeke, CS, Sarasqueta, AF, de Boer, O. Artificial Intelligence-based Segmentation of Residual Pancreatic Cancer in Resection Specimens Following Neoadjuvant Treatment (ISGPP-2). American Journal of Surgical Pathology 48(9):1108-1116, 2024. e-Pub 2024. PMID: 38985503.
9. Yang, Y, Wang, J, Wan, J, Cheng, Q, Cheng, Z, Zhou, X, Wang, OH, Shi, K, Wang, L, Wang, B, Zhu, X, Chen, J, Feng, D, Liu, Y, Jahan-mihan, Y, Haddock, AN, Edenfield, BH, Peng, G, Hohenstein, JD, McCabe, CE, O'Brien, D, Wang, C, Ilyas, SI, Jiang, L, Torbenson, M, Wang, H, Nakhleh, RE, Shi, X, Wang, Y, Bi, Y, Gores, GJ, Patel, T, Ji, B. PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice. Journal of Hepatology 81(1):120-134, 2024. e-Pub 2024. PMID: 38428643.
10. Yang, D, Sun, X, Moniruzzaman, R, Wang, H, Citu, C, Zhao, Z, Wistuba, II, Wang, H, Maitra, A, Chen, Y. Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy. Gastroenterology 167(2):298-314, 2024. e-Pub 2024. PMID: 38467382.
11. Mahadevan, KK, Dyevoich, AM, Chen, Y, Li, B, Sugimoto, H, Sockwell, AM, McAndrews, KM, Sthanam, LK, Wang, H, Shalapour, S, Watowich, SS, Kalluri, R. Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer. Science 384(6703), 2024. e-Pub 2024. PMID: 38935717.
12. Zou, G, Huang, Y, Zhang, S, Ko, KP, Kim, B, Zhang, J, Venkatesan, V, Pizzi, M, Fan, Y, Jun, S, Niu, N, Wang, H, Song, S, Ajani, JA, Park, J. E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming. Journal of Experimental Medicine 221(4), 2024. e-Pub 2024. PMID: 38411616.
13. Yousef A, Yousef M, Chowdhury S, Abdilleh K, Knafl M, Edelkamp P, Alfaro-Munoz K, Chacko R, Peterson J, Smaglo BG, Wolff RA, Pant S, Lee MS, Willis J, Overman M, Doss S, Matrisian L, Hurd MW, Snyder R, Katz MHG, Wang H, Maitra A, Shen JP, Zhao D. Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma. NPJ Precis Oncol 8(1):27, 2024. e-Pub 2024. PMID: 38310130.
14. Dhingra S, Taggart MW, Foo WC, Rashid A, Heredia MLM, May SB, Van Buren G, Fisher WE, Wang H. Interobserver Variability and Challenges in Intraoperative Frozen Section Evaluation of Pancreatic Margins in Pancreatectomy Specimens. Ann Clin Lab Sci 53(6):847-860, 2023. e-Pub 2023. PMID: 38182140.
15. Lv, X, Lu, X, Cao, J, Luo, Q, Ding, Y, Peng, F, Pataer, A, Lu, D, Han, D, Malmberg, E, Chan, DW, Wang, X, Savage, SR, Mao, S, Yu, J, Peng, F, Yan, L, Meng, H, Maneix, L, Han, Y, Chen, Y, Yao, W, Chang, EC, Catic, A, Lin, X, Miles, G, Huang, P, Sun, Z, Burt, BM, Wang, H, Wang, J, Yao, Q, Zhang, B, Roth, JA, O’Malley, BW, Ellis, MJ, Rimawi, MF, Ying, H, Chen, X. Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. Science 381(6662), 2023. e-Pub 2023. PMID: 37676964.
16. Zhang, Y, Wang, H, Overman, MJ, Katz, MH, Wang, H. Prognostic significance of trophoblastic cell surface antigen 2 expression and pathologic parameters in patients with ampullary adenocarcinoma. Human Pathology 139:117-125, 2023. e-Pub 2023. PMID: 37516386.
17. Ngo-Huang, AT, Parker, NH, Xiao, L, Schadler, KL, Petzel, MQ, Prakash, L, Kim, M, Tzeng, CD, Lee, JE, Ikoma, N, Wolff, RA, Javle, M, Koay, EJ, Pant, S, Folloder, J, Wang, X, Cotto, AM, Ju, YR, Garg, N, Wang, H, Bruera, E, Basen-Engquist, KM, Katz, MH. Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer. Annals of surgery 278(1):22-30, 2023. e-Pub 2023. PMID: 37026453.
18. Liang TZ, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Ikoma N, Wolff RA, Zhao D, Koay EJ, Maitra A, Kundu S, Wang H. Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy. Cancers (Basel) 15(12), 2023. e-Pub 2023. PMID: 37370842.
19. Wang H, Moniruzzaman R, Li L, Ji B, Liu Y, Zuo X, Abbasgholizadeh R, Zhao J, Liu G, Wang R, Tang H, Sun R, Su X, Tan TH, Maitra A, Wang H. Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasia. J Clin Invest 133(12), 2023. e-Pub 2023. PMID: 37140994.
20. Tong YT, Lai Z, Katz MHG, Prakash LR, Wang H, Chatterjee D, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Maitra A, Wang H. Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy. Cancers (Basel) 15(9), 2023. e-Pub 2023. PMID: 37174073.
21. Yang D, Moniruzzaman R, Wang H, Wang H, Chen Y. Cross-Dataset Single-Cell Analysis Identifies Temporal Alterations in Cell Populations of Primary Pancreatic Tumor and Liver Metastasis. Cancers (Basel) 15(8), 2023. e-Pub 2023. PMID: 37190324.
22. Sohn AJ, Taherian M, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Sun R, Maitra A, Wang H. Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Am J Surg Pathol 47(4):421-430, 2023. e-Pub 2023. PMID: 36746143.
23. Zhang, X, Yao, J, Niu, N, Li, X, Liu, Y, Huo, L, Euscher, ED, Wang, H, Bell, D, Sood, AK, Wang, G, Lawson, BC, Ramalingam, P, Malpica, A, Sahin, AA, Ding, Q, Liu, J. SOX17. Modern Pathology 36(2), 2023. e-Pub 2023. PMID: 36853778.
24. Gulhati P, Schalck A, Jiang S, Shang X, Wu CJ, Hou P, Ruiz SH, Soto LS, Parra E, Ying H, Han J, Dey P, Li J, Deng P, Sei E, Maeda DY, Zebala JA, Spring DJ, Kim M, Wang H, Maitra A, Moore D, Clise-Dwyer K, Wang YA, Navin NE, DePinho RA. Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer. Nat Cancer 4(1):62-80, 2023. e-Pub 2023. PMID: 36585453.
25. Kang Y, Deng J, Ling J, Li X, Chiang YJ, Koay EJ, Wang H, Burks JK, Chiao PJ, Hurd MW, Bhutani MS, Lee JH, Weston BR, Maitra A, Ikoma N, Tzeng CD, Lee JE, DePinho RA, Wolff RA, Pant S, McAllister F, Katz MH, Fleming JB, Kim MP. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. J Clin Invest 132(24), 2022. e-Pub 2022. PMID: 36282600.
26. Janssen BV, van Roessel S, van Dieren S, de Boer O, Adsay V, Basturk O, Brosens L, Campbell F, Chatterjee D, Chou A, Doglioni C, Esposito I, Feakins R, Fuchs TL, Fukushima N, Gill AJ, Hong SM, Hruban RH, Kaplan J, Krasinkas A, Luchini C, Shi C, Singhi A, Thompson E, Velthuysen MF, Besselink MG, Verheij J, Wang H, Verbeke C, Fariña A, Pancreatic Pathologists ISGO. Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1). Br J Surg 110(1):67-75, 2022. e-Pub 2022. PMID: 36331867.
27. Koay EJ, Zaid M, Aliru M, Bagereka P, Van Wieren A, Rodriguez MJ, Jacobson G, Wolff RA, Overman M, Varadhachary G, Pant S, Wang H, Tzeng CW, Ikoma N, Kim M, Lee JE, Katz MH, Tamm E, Bhosale P, Taniguchi CM, Holliday EB, Smith GL, Ludmir EB, Minsky BD, Crane CH, Koong AC, Das P, Wang X, Javle M, Krishnan S. Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker Validation. Int J Radiat Oncol Biol Phys 114(3):444-453, 2022. e-Pub 2022. PMID: 35863672.
28. Glorieux C, Xia X, You X, Wang Z, Han Y, Yang J, Noppe G, Meester C, Ling J, Robert A, Zhang H, Li SP, Wang H, Chiao PJ, Zhang L, Li X, Huang P. Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancer. J Adv Res 40:109-124, 2022. e-Pub 2022. PMID: 36100320.
29. Wang CX, Elganainy D, Zaid MM, Butner JD, Agrawal A, Nizzero S, Minsky BD, Holliday EB, Taniguchi CM, Smith GL, Koong AC, Herman JM, Das P, Maitra A, Wang H, Wolff RA, Katz MH, Crane CH, Cristini V, Koay EJ. Mass transport model of radiation response: calibration and application to chemoradiation for pancreatic cancer. Int J Radiat Oncol Biol Phys 114(1):163-172, 2022. e-Pub 2022. PMID: 35643254.
30. Chen Y, Yang S, Tavormina J, Tampe D, Zeisberg M, Wang H, Mahadevan KK, Wu CJ, Sugimoto H, Chang CC, Jenq RR, McAndrews KM, Kalluri R. Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer. Cancer Cell 40(8):818-834.e9, 2022. e-Pub 2022. PMID: 35868307.
31. Wangzhou K, Wen JJ, Wang Z, Wang H, Hao C, Andlib Z. Revealing the nexus between tourism development and CO2 emissions in Asia: does asymmetry matter?. Environ Sci Pollut Res Int. e-Pub 2022. PMID: 35705760.
32. Wang H, Chetty R, Hosseini M, Allende DS, Esposito I, Matsuda Y, Deshpande V, Shi J, Dhall D, Jang KT, Kim GE, Luchini C, Graham RP, Reid MD, Basturk O, Hruban RH, Krasinskas A, Klimstra DS, Adsay V, Society PP. Pathologic Examination of Pancreatic Specimens Resected for Treated Pancreatic Ductal Adenocarcinoma: Recommendations From the Pancreatobiliary Pathology Society. Am J Surg Pathol 46(6):754-764, 2022. e-Pub 2022. PMID: 34889852.
33. McAndrews KM, Chen Y, Darpolor JK, Zheng X, Yang S, Carstens JL, Li B, Wang H, Miyake T, Correa de Sampaio P, Kirtley ML, Natale M, Wu CC, Sugimoto H, LeBleu VS, Kalluri R. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer. Cancer Discov 12(6):1580-1597, 2022. e-Pub 2022. PMID: 35348629.
34. Hernandez S, Parra ER, Uraoka N, Tang X, Shen Y, Qiao W, Jiang M, Zhang S, Mino B, Lu W, Pandurengan R, Haymaker C, Affolter K, Scaife CL, Yip-Schneider M, Schmidt CM, Firpo MA, Mulvihill SJ, Koay EJ, Wang H, Wistuba II, Maitra A, Solis LM, Sen S. Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception. Clin Cancer Res 28(9):1938-1947, 2022. e-Pub 2022. PMID: 35491652.
35. Zhang Y, Chen X, Wang H, Gordon-Mitchell S, Sahu S, Bhagat TD, Choudhary G, Aluri S, Pradhan K, Sahu P, Carbajal M, Zhang H, Agarwal B, Shastri A, Martell R, Starczynowski D, Steidl U, Maitra A, Verma A. Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer. J Hematol Oncol 15(1):70, 2022. e-Pub 2022. PMID: 35606824.
36. Liu Y, Deguchi Y, Wei D, Liu F, Moussalli MJ, Deguchi E, Li D, Wang H, Valentin LA, Colby JK, Wang J, Zheng X, Ying H, Gagea M, Ji B, Shi J, Yao JC, Zuo X, Shureiqi I. Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ. Nat Commun 13(1):2665, 2022. e-Pub 2022. PMID: 35562376.
37. Alam A, Levanduski E, Denz P, Villavicencio HS, Bhatta M, Alhorebi L, Zhang Y, Gomez EC, Morreale B, Senchanthisai S, Li J, Turowski SG, Sexton S, Sait SJ, Singh PK, Wang J, Maitra A, Kalinski P, DePinho RA, Wang H, Liao W, Abrams SI, Segal BH, Dey P. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell 40(2):153-167.e11, 2022. e-Pub 2022. PMID: 35120601.
38. Chen Y, Capello M, Rios Perez MV, Vykoukal JV, Roife D, Kang Y, Prakash LR, Katayama H, Irajizad E, Fleury A, Ferri-Borgogno S, Baluya DL, Dennison JB, Do KA, Fiehn O, Maitra A, Wang H, Chiao PJ, Katz MHG, Fleming JB, Hanash SM, Fahrmann JF. CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop. Mol Metab 56:101426, 2022. e-Pub 2022. PMID: 34971802.
39. Yu Y, Chang K, Chen JS, Bohlender RJ, Fowler J, Zhang D, Huang M, Chang P, Li Y, Wong J, Wang H, Gu J, Wu X, Schildkraut J, Cannon-Albright L, Ye Y, Zhao H, Hildebrandt MAT, Permuth JB, Li D, Scheet P, Huff CD. A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk. HGG Adv 3(1):100078, 2022. e-Pub 2022. PMID: 35047863.
40. Tong YT, Wang H, Wei D, Prakash LR, Kim M, Tzeng CD, Lee JE, Rashid A, Koay EJ, Wolff RA, Maitra A, Katz MH, Wang H. GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first. Pancreatology 21(7):1378-1385, 2021. e-Pub 2021. PMID: 34429247.
41. Zhao J, Soto LMS, Wang H, Katz MH, Prakash LR, Kim M, Tzeng CD, Lee JE, Wolff RA, Huang Y, Wistuba II, Maitra A, Wang H. Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival. Pancreatology 21(5):942-949, 2021. e-Pub 2021. PMID: 33832821.
42. Chou PC, Choi HH, Huang Y, Fuentes-Mattei E, Velazquez-Torres G, Zhang F, Phan L, Lee J, Shi Y, Bankson JA, Wu Y, Wang H, Zhao R, Yeung SJ, Lee MH. Impact of diabetes on promoting the growth of breast cancer. Cancer Commun (Lond) 41(5):414-431, 2021. e-Pub 2021. PMID: 33609419.
43. Chen Y, Kim J, Yang S, Wang H, Wu CJ, Sugimoto H, LeBleu VS, Kalluri R. Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell 39(4):548-565.e6, 2021. e-Pub 2021. PMID: 33667385.
44. Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer. Mod Pathol 34(4):710-719, 2021. e-Pub 2021. PMID: 33011748.
45. Perri G, Prakash L, Wang H, Bhosale P, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay E, Herman J, Kim M, Ikoma N, Tzeng CW, Lee JE, Katz MHG. Radiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic Cancer. Ann Surg 273(4):806-813, 2021. e-Pub 2019. PMID: 31274655.
46. Sun L, Zhang X, Song Q, Liu L, Forbes E, Tian W, Zhang Z, Kang Y, Wang H, Fleming JB, Pasche BC, Zhang W. IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway. Cancer Lett 500:132-146, 2021. e-Pub 2021. PMID: 33309859.
47. Francescone R, Barbosa Vendramini-Costa D, Franco-Barraza J, Wagner J, Muir A, Lau AN, Gabitova L, Pazina T, Gupta S, Luong T, Rollins D, Malik R, Thapa RJ, Restifo D, Zhou Y, Cai KQ, Hensley HH, Tan Y, Kruger WD, Devarajan K, Balachandran S, Klein-Szanto AJ, Wang H, El-Deiry WS, Vander Heiden MG, Peri S, Campbell KS, Astsaturov I, Cukierman E. Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast-Driven Nutritional Support and Immunosuppression. Cancer Discov 11(2):446-479, 2021. e-Pub 2021. PMID: 33127842.
48. Janssen BV, Tutucu F, van Roessel S, Adsay V, Basturk O, Campbell F, Doglioni C, Esposito I, Feakins R, Fukushima N, Gill AJ, Hruban RH, Kaplan J, Koerkamp BG, Hong SM, Krasinskas A, Luchini C, Offerhaus J, Sarasqueta AF, Shi C, Singhi A, Stoop TF, Soer EC, Thompson E, van Tienhoven G, Velthuysen MF, Wilmink JW, Besselink MG, Brosens LAA, Wang H, Verbeke CS, Verheij J, Pancreatic Pathologists ISGO. Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy. Mod Pathol 34(1):4-12, 2021. e-Pub 2021. PMID: 33041332.
49. Wei D, Zaid MM, Katz MH, Prakash LR, Kim M, Tzeng CD, Lee JE, Agrawal A, Rashid A, Wang H, Varadhachary G, Wolff RA, Tamm EP, Bhosale PR, Maitra A, Koay EJ, Wang H. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. Pancreatology 21(1):200-207, 2021. e-Pub 2021. PMID: 33221151.
50. Zhang Y, Chandra V, Riquelme Sanchez E, Dutta P, Quesada PR, Rakoski A, Zoltan M, Arora N, Baydogan S, Horne W, Burks J, Xu H, Hussain P, Wang H, Gupta S, Maitra A, Bailey JM, Moghaddam SJ, Banerjee S, Sahin I, Bhattacharya P, McAllister F. Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer. J Exp Med 217(12), 2020. e-Pub 2020. PMID: 32860704.
51. Zaid M, Widmann L, Dai A, Sun K, Zhang J, Zhao J, Hurd MW, Varadhachary GR, Wolff RA, Maitra A, Katz MHG, Herman JM, Wang H, Knopp MV, Williams TM, Bhosale P, Tamm EP, Koay EJ. Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study. Cancers (Basel) 12(12), 2020. e-Pub 2020. PMID: 33291471.
52. Banh RS, Biancur DE, Yamamoto K, Sohn ASW, Walters B, Kuljanin M, Gikandi A, Wang H, Mancias JD, Schneider RJ, Pacold ME, Kimmelman AC. Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer. Cell 183(5):1202-1218.e25, 2020. e-Pub 2020. PMID: 33142117.
53. Colina A, Hwang H, Wang H, Katz MHG, Sun R, Lee JE, Thomas J, Tzeng CW, Wolff RA, Raghav K, Overman MJ. Natural history and prognostic factors for localised small bowel adenocarcinoma. ESMO Open 5(6):e000960, 2020. e-Pub 2020. PMID: 33188051.
54. Ma Y, Li J, Wang H, Chiu Y, Kingsley CV, Fry D, Delaney SN, Wei SC, Zhang J, Maitra A, Yee C. Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer. Gastroenterology 159(1):306-319.e12, 2020. e-Pub 2020. PMID: 32179091.
55. Parker SJ, Amendola CR, Hollinshead KER, Yu Q, Yamamoto K, Encarnación-Rosado J, Rose RE, LaRue MM, Sohn ASW, Biancur DE, Paulo JA, Gygi SP, Jones DR, Wang H, Philips MR, Bar-Sagi D, Mancias JD, Kimmelman AC. Selective Alanine Transporter Utilization Creates a Targetable Metabolic Niche in Pancreatic Cancer. Cancer Discov 10(7):1018-1037, 2020. e-Pub 2020. PMID: 32341021.
56. Wang Z, Hausmann S, Lyu R, Li TM, Lofgren SM, Flores NM, Fuentes ME, Caporicci M, Yang Z, Meiners MJ, Cheek MA, Howard SA, Zhang L, Elias JE, Kim MP, Maitra A, Wang H, Bassik MC, Keogh MC, Sage J, Gozani O, Mazur PK. SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. Cancer Cell 37(6):834-849.e13, 2020. e-Pub 2020. PMID: 32442403.
57. Prakash LR, Wang H, Zhao J, Nogueras-Gonzalez GM, Cloyd JM, Tzeng CD, Kim MP, Lee JE, Katz MHG. Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection. J Gastrointest Surg 24(2):368-379, 2020. e-Pub 2020. PMID: 30820801.
58. Dey P, Li J, Zhang J, Chaurasiya S, Strom A, Wang H, Liao WT, Cavallaro F, Denz P, Bernard V, Yen EY, Genovese G, Gulhati P, Liu J, Chakravarti D, Deng P, Zhang T, Carbone F, Chang Q, Ying H, Shang X, Spring DJ, Ghosh B, Putluri N, Maitra A, Wang YA, DePinho RA. Oncogenic Kras driven metabolic reprogramming in pancreas cancer cells utilizes cytokines from the tumor microenvironment. Cancer Discov. e-Pub 2020. PMID: 32046984.
59. Song X, Akasaka H, Wang H, Abbasgholizadeh R, Shin JH, Zang F, Chen J, Logsdon CD, Maitra A, Bean AJ, Wang H. Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer. J Biol Chem 295(8):2348-2358, 2020. e-Pub 2020. PMID: 31959629.
60. Tu B, Yao J, Ferri-Borgogno S, Zhao J, Chen S, Wang Q, Yan L, Zhou X, Zhu C, Bang S, Chang Q, Bristow CA, Kang Y, Zheng H, Wang H, Fleming JB, Kim M, Heffernan TP, Draetta GF, Pan D, Maitra A, Yao W, Gupta S, Ying H. YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma. JCI Insight 4(21), 2019. e-Pub 2019. PMID: 31557131.
61. Wang M, Estrella JS, Katz MH, Kim M, Rashid A, Lee JE, Maitra A, Wistuba II, Wolff RA, Varadhachary GR, Wang H. Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma. Pancreas 48(10):1367-1372, 2019. e-Pub 2019. PMID: 31688603.
62. Hou P, Ma X, Zhang Q, Wu CJ, Liao W, Li J, Wang H, Zhao J, Zhou X, Guan C, Ackroyd J, Jiang S, Zhang J, Spring DJ, Wang YA, DePinho RA. USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation. Genes Dev 33(19-20):1361-1366, 2019. e-Pub 2019. PMID: 31488580.
63. Florez Bedoya CA, Cardoso ACF, Parker N, Ngo-Huang A, Petzel MQ, Kim MP, Fogelman D, Romero SG, Wang H, Park M, Katz MHG, Schadler KL. Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients. Sci Rep 9(1):13966, 2019. e-Pub 2019. PMID: 31562341.
64. Huang H, Swidnicka-Siergiejko AK, Daniluk J, Gaiser S, Yao Y, Peng L, Zhang Y, Liu Y, Dong M, Zhan X, Wang H, Bi Y, Li Z, Ji B, Logsdon CD. Transgenic Expression of PRSS1R122H Sensitizes Mice to Pancreatitis. Gastroenterology. e-Pub 2019. PMID: 31419436.
65. Yao W, Rose JL, Wang W, Seth S, Jiang H, Taguchi A, Liu J, Yan L, Kapoor A, Hou P, Chen Z, Wang Q, Nezi L, Xu Z, Yao J, Hu B, Pettazzoni PF, Ho IL, Feng N, Ramamoorthy V, Jiang S, Deng P, Ma GJ, Den P, Tan Z, Zhang SX, Wang H, Wang YA, Deem AK, Fleming JB, Carugo A, Heffernan TP, Maitra A, Viale A, Ying H, Hanash S, DePinho RA, Draetta GF. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature 568(7752):410-414, 2019. e-Pub 2019. PMID: 30918400.
66. Wang EM, Akasaka H, Zhao J, Varadhachary GR, Lee JE, Maitra A, Fleming JB, Hung MC, Wang H, Katz MHG. Expression and Clinical Significance of Protein Kinase RNA-Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2α in Pancreatic Ductal Adenocarcinoma. Pancreas 48(3):323-328, 2019. e-Pub 2019. PMID: 30747823.
67. Gulhati P, Prakash L, Katz MHG, Wang X, Javle M, Shroff R, Fogelman D, Lee JE, Tzeng CD, Lee JH, Weston B, Tamm E, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GR. First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 26(2):619-627, 2019. e-Pub 2019. PMID: 30324485.
68. Adam L, San Lucas FA, Fowler R, Yu Y, Wu W, Liu Y, Wang H, Menter D, Tetzlaff MT, Ensor J, Manyam G, Arold ST, Huff C, Kopetz S, Scheet P, Overman MJ. DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway. Clin Cancer Res 25(2):641-651, 2019. e-Pub 2019. PMID: 30352910.
69. Huang H, Chen J, Peng L, Yao Y, Deng D, Zhang Y, Liu Y, Wang H, Li Z, Bi Y, Haddock AN, Zhan X, Lu W, Logsdon CD, Ji B. Transgenic expression of cyclooxygenase-2 in pancreatic acinar cells induces chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 316(1):G179-G186, 2019. e-Pub 2019. PMID: 30431318.
70. Liu S, Hausmann S, Carlson SM, Fuentes ME, Francis JW, Pillai R, Lofgren SM, Hulea L, Tandoc K, Lu J, Li A, Nguyen ND, Caporicci M, Kim MP, Maitra A, Wang H, Wistuba II, Porco JA, Bassik MC, Elias JE, Song J, Topisirovic I, Van Rechem C, Mazur PK, Gozani O. METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis. Cell 176(3):491-504.e21, 2019. e-Pub 2019. PMID: 30612740.
71. Blando J, Sharma A, Higa MG, Zhao H, Vence L, Yadav SS, Kim J, Sepulveda AM, Sharp M, Maitra A, Wargo J, Tetzlaff M, Broaddus R, Katz MHG, Varadhachary GR, Overman M, Wang H, Yee C, Bernatchez C, Iacobuzio-Donahue C, Basu S, Allison JP, Sharma P. Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer. Proc Natl Acad Sci U S A 116(5):1692-1697, 2019. e-Pub 2019. PMID: 30635425.
72. Koay EJ, Katz MHG, Wang H, Wang X, Prakash L, Javle M, Shroff R, Fogelman D, Avila S, Zaid M, Elganainy D, Lee Y, Crane CH, Krishnan S, Das P, Fleming JB, Lee JE, Tamm EP, Bhosale P, Lee JH, Weston B, Maitra A, Wolff RA, Varadhachary GR. Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer. JCO Precis Oncol 3, 2019. e-Pub 2019. PMID: 32914036.
73. Koay EJ, Lee Y, Cristini V, Lowengrub JS, Kang Y, Lucas FAS, Hobbs BP, Ye R, Elganainy D, Almahariq M, Amer AM, Chatterjee D, Yan H, Park PC, Rios Perez MV, Li D, Garg N, Reiss KA, Yu S, Chauhan A, Zaid M, Nikzad N, Wolff RA, Javle M, Varadhachary GR, Shroff RT, Das P, Lee JE, Ferrari M, Maitra A, Taniguchi CM, Kim MP, Crane CH, Katz MH, Wang H, Bhosale P, Tamm EP, Fleming JB. A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 24(23):5883-5894, 2018. e-Pub 2018. PMID: 30082477.
74. Sharib JM, Fonseca AL, Swords DS, Jaradeh K, Bracci PM, Firpo MA, Hatcher S, Scaife CL, Wang H, Kim GE, Mulvihill SJ, Maitra A, Koay EJ, Kirkwood KS. Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?. Surgery 164(6):1178-1184, 2018. e-Pub 2018. PMID: 30170819.
75. Zhou L, Husted H, Moore T, Lu M, Deng D, Liu Y, Ramachandran V, Arumugam T, Niehrs C, Wang H, Chiao P, Ling J, Curran MA, Maitra A, Hung MC, Lee JE, Logsdon CD, Hwang RF. Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma. Sci Transl Med 10(464), 2018. e-Pub 2018. PMID: 30355799.
76. Zhang Y, Zoltan M, Riquelme E, Xu H, Sahin I, Castro-Pando S, Montiel MF, Chang K, Jiang Z, Ling J, Gupta S, Horne W, Pruski M, Wang H, Sun SC, Lozano G, Chiao P, Maitra A, Leach SD, Kolls JK, Vilar E, Wang TC, Bailey JM, McAllister F. Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells. Gastroenterology 155(1):210-223.e3, 2018. e-Pub 2018. PMID: 29604293.
77. Peng JM, Bera R, Chiou CY, Yu MC, Chen TC, Chen CW, Wang TR, Chiang WL, Chai SP, Wei Y, Wang H, Hung MC, Hsieh SY. Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis in mice. Hepatology 67(6):2226-2243, 2018. e-Pub 2018. PMID: 29171033.
78. Hui L, Rashid A, Foo WC, Katz MH, Chatterjee D, Wang H, Fleming JB, Tamm EP, Wang H. Significance of T1a and T1b Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas. Am J Surg Pathol 42(5):578-586, 2018. e-Pub 2018. PMID: 29462092.
79. Amer AM, Zaid M, Chaudhury B, Elganainy D, Lee Y, Wilke CT, Cloyd J, Wang H, Maitra A, Wolff RA, Varadhachary G, Overman MJ, Lee JE, Fleming JB, Tzeng CW, Katz MH, Holliday EB, Krishnan S, Minsky BD, Herman JM, Taniguchi CM, Das P, Crane CH, Le O, Bhosale P, Tamm EP, Koay EJ. Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy. Cancer 124(8):1701-1709, 2018. e-Pub 2018. PMID: 29370450.
80. Wang YN, Lee HH, Chou CK, Yang WH, Wei Y, Chen CT, Yao J, Hsu JL, Zhu C, Ying H, Ye Y, Wang WJ, Lim SO, Xia W, Ko HW, Liu X, Liu CG, Wu X, Wang H, Li D, Prakash LR, Katz MH, Kang Y, Kim M, Fleming JB, Fogelman D, Javle M, Maitra A, Hung MC. Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer. Cancer Cell 33(4):752-769.e8, 2018. e-Pub 2018. PMID: 29606349.
81. Zhao J, Wang H, Hsiao CH, Chow DS, Koay EJ, Kang Y, Wen X, Huang Q, Ma Y, Bankson JA, Ullrich SE, Overwijk W, Maitra A, Piwnica-Worms D, Fleming JB, Li C. Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy. Biomaterials 159:215-228, 2018. e-Pub 2018. PMID: 29331808.
82. Gulhati P, Raghav K, Shroff R, Varadhachary G, Javle M, Qiao W, Wang H, Morris J, Wolff R, Overman MJ. Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater. Oncologist 23(3):277-e26, 2018. e-Pub 2018. PMID: 29259073.
83. Barua S, Solis L, Parra ER, Uraoka N, Jiang M, Wang H, Rodriguez-Canales J, Wistuba I, Maitra A, Sen S, Rao A. A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous Neoplasms. Cancer Inform 17:1176935118782880, 2018. e-Pub 2018. PMID: 30013304.
84. Cuglievan B, Subbiah V, Wang H, Morani A, Meric-Bernstam F, Holla V, Herzog CE. Response to Mammalian Target of Rapamycin-Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mutation. JCO Precis Oncol 2, 2018. e-Pub 2018. PMID: 31650099.
85. Yamashita S, Overman MJ, Wang H, Zhao J, Okuno M, Goumard C, Tzeng CW, Kim M, Fleming JB, Vauthey JN, Katz MH, Lee JE, Conrad C. Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma. Ann Surg Oncol 24(13):3954-3963, 2017. e-Pub 2017. PMID: 28980211.
86. Aguilera KY, Huang H, Du W, Hagopian MM, Wang Z, Hinz S, Hwang TH, Wang H, Fleming JB, Castrillon DH, Ren X, Ding K, Brekken RA. Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma. Mol Cancer Ther 16(11):2473-2485, 2017. e-Pub 2017. PMID: 28864681.
87. Nejati R, Goldstein JB, Halperin DM, Wang H, Hejazi N, Rashid A, Katz MH, Lee JE, Fleming JB, Rodriguez-Canales J, Blando J, Wistuba II, Maitra A, Wolff RA, Varadhachary GR, Wang H. Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy. Pancreas 46(9):1180-1187, 2017. e-Pub 2017. PMID: 28902789.
88. Lu SX, Zhang CZ, Luo RZ, Wang CH, Liu LL, Fu J, Zhang L, Wang H, Xie D, Yun JP. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma. Cancer Lett 402:71-80, 2017. e-Pub 2017. PMID: 28577975.
89. Chatterjee D, Katz MH, Foo WC, Sundar M, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Fleming JB, Rashid A, Wang H. Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy. Am J Surg Pathol 41(8):1097-1104, 2017. e-Pub 2017. PMID: 28614206.
90. Cloyd JM, Katz MHG, Wang H, Cuddy A, You YN. Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Patients With Pancreatic Ductal Adenocarcinoma. JAMA Surg. e-Pub 2017. PMID: 28793134.
91. Cloyd JM, Wang H, Egger ME, Tzeng CD, Prakash LR, Maitra A, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Overman MJ, Koay EJ, Das P, Herman JM, Kim MP, Vauthey JN, Aloia TA, Fleming JB, Lee JE, Katz MHG. Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma. JAMA Surg. e-Pub 2017. PMID: 28700784.
92. Swidnicka-Siergiejko AK, Gomez-Chou SB, Cruz-Monserrate Z, Deng D, Liu, Y, Huang H, Ji B, Azizian, N, Daniluk J, Lu W, Wang H, Maitra A, Logsdon CD. Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53. Oncogene:314-3158, 2017. e-Pub 2017. PMID: 27991926.
93. Capello M, Bantis LE, Scelo G, Zhao Y, Li P, Dhillon DS, Patel NJ, Kundnani DL, Wang H, Abbruzzese JL, Maitra A, Tempero MA, Brand R, Firpo MA, Mulvihill SJ, Katz MH, Brennan P, Feng Z, Taguchi A, Hanash SM. Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. J Natl Cancer Inst 109(4), 2017. e-Pub 2017. PMID: 28376157.
94. Carstens JL, Correa de Sampaio P, Yang D, Barua S, Wang H, Rao A, Allison JP, LeBleu VS, Kalluri R. Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer. Nat Commun 8:15095, 2017. e-Pub 2017. PMID: 28447602.
95. Gomez-Chou S, Swidnicka-Siergiejko A, Badi N, Chavez-Tomar M, Lesinski GB, Bekaii-Saab T, Farren MR, Mace TA, Schmidt C, Liu Y, Deng D, Hwang RF, Zhou L, Moore TT, Chatterjee D, Wang H, Leng X, Arlinghaus RB, Logsdon CD, Cruz-Monserrate Z. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment. Cancer Res. e-Pub 2017. PMID: 28249896.
96. Mao Y, Shen J, Lu Y, Lin K, Wang H, Li Y, Chang P, Walker MG, Li D. RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancer. Oncotarget. e-Pub 2017. PMID: 28418924.
97. Wang F, Ma Y, Wang H, Qin H. Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer. Oncol Lett 13(3):1048-1057, 2017. e-Pub 2017. PMID: 28454212.
98. Genovese G, Carugo A, Tepper J, Robinson FS, Li L, Svelto M, Nezi L, Corti D, Minelli R, Pettazzoni P, Gutschner T, Wu CC, Seth S, Akdemir KC, Leo E, Amin S, Molin MD, Ying H, Kwong LN, Colla S, Takahashi K, Ghosh P, Giuliani V, Muller F, Dey P, Jiang S, Garvey J, Liu CG, Zhang J, Heffernan TP, Toniatti C, Fleming JB, Goggins MG, Wood LD, Sgambato A, Agaimy A, Maitra A, Roberts CW, Wang H, Viale A, DePinho RA, Draetta GF, Chin L. Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. Nature 542(7641):362-366, 2017. e-Pub 2017. PMID: 28178232.
99. Ju HQ, Ying H, Tian T, Ling J, Fu J, Lu Y, Wu M, Yang L, Achreja A, Chen G, Zhuang Z, Wang H, Nagrath D, Yao J, Hung MC, DePinho RA, Huang P, Xu RH, Chiao PJ. Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma. Nat Commun 8:14437, 2017. e-Pub 2017. PMID: 28232723.
100. Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. J Gastrointest Surg 21(1):164-174, 2017. e-Pub 2017. PMID: 27778257.
101. Dey P, Baddour J, Muller F, Wu CC, Wang H, Liao WT, Lan Z, Chen A, Gutschner T, Kang Y, Fleming J, Satani N, Zhao D, Achreja A, Yang L, Lee J, Chang E, Genovese G, Viale A, Ying H, Draetta G, Maitra A, Wang YA, Nagrath D, DePinho RA. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. Nature. e-Pub 2017. PMID: 28099419.
102. Cloyd JM, Wang H, Overman M, Zhao J, Denbo J, Prakash L, Kim MP, Shroff R, Javle M, Varadhachary GR, Fogelman D, Wolff RA, Koay EJ, Das P, Maitra A, Aloia TA, Vauthey JN, Fleming JB, Lee JE, Katz MH. Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater. Ann Surg Oncol. e-Pub 2017. PMID: 28124275.
103. Liu Q, Stewart J, Wang H, Rashid A, Zhao J, Katz MH, Lee JE, Fleming JB, Maitra A, Wolff RA, Varadhachary GR, Krishnan S, Wang H. Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma. PLoS One 12(2):e0171985, 2017. e-Pub 2017. PMID: 28187218.
104. Wang Y, Hsu JM, Kang Y, Wei Y, Lee PC, Chang SJ, Hsu YH, Hsu JL, Wang HL, Chang WC, Li CW, Liao HW, Chang SS, Xia W, Ko HW, Chou CK, Fleming JB, Wang H, Hwang RF, Chen Y, Qin J, Hung MC. Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation. Cancer Res 76(23):7049-7058, 2016. e-Pub 2016. PMID: 27758883.
105. Luo Z, Li Y, Zuo M, Liu C, Yan D, Wang H, Li D. Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers. Mol Carcinog. e-Pub 2016. PMID: 27996162.
106. Lee SM, Katz MH, Liu L, Sundar M, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Fleming JB, Rashid A, Wang H. Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival. Am J Surg Pathol 40(12):1653-1660, 2016. e-Pub 2016. PMID: 27631521.
107. Gulhati P, Raghav K, Shroff RT, Varadhachary GR, Kopetz S, Javle M, Qiao W, Wang H, Morris J, Wolff RA, Overman MJ. Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study. Cancer 123(6):1011-1017, 2016. e-Pub 2016. PMID: 27859010.
108. Kang Y, Roife D, Lee Y, Lv H, Suzuki R, Ling J, Rios Perez MV, Li X, Dai B, Pratt M, Truty MJ, Chatterjee D, Wang H, Thomas RM, Wang Y, Koay EJ, Chiao PJ, Katz MH, Fleming JB. Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Clin Cancer Res 22(19):4934-4946, 2016. e-Pub 2016. PMID: 27126993.
109. Ma Y, Yang Y, Wang F, Moyer MP, Wei Q, Zhang P, Yang Z, Liu W, Zhang H, Chen N, Wang H, Wang H, Qin H. Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α. Gut 65(9):1494-504, 2016. e-Pub 2016. PMID: 25994219.
110. Cloyd JM, Crane CH, Koay EJ, Das P, Krishnan S, Prakash L, Snyder RA, Varadhachary GR, Wolff RA, Javle M, Shroff RT, Fogelman D, Overman M, Wang H, Maitra A, Lee JE, Fleming JB, Katz MH. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Cancer 122(17):2671-9, 2016. e-Pub 2016. PMID: 27243381.
111. Gao S, Sun Y, Zhang X, Hu L, Liu Y, Chua CY, Phillips LM, Ren H, Fleming JB, Wang H, Chiao PJ, Hao J, Zhang W. IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma. Cancer Res 76(22):1-12. e-Pub 2016. PMID: 27659045.
112. Overman MJ, Soifer HS, Schueneman AJ, Ensor J, Adsay V, Saka B, Neishaboori N, Wolff RA, Wang H, Schnabel CA, Varadhachary G. Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma. BMC Cancer 16:668, 2016. e-Pub 2016. PMID: 27549176.
113. Hanania AN, Bantis LE, Feng Z, Wang H, Tamm EP, Katz MH, Maitra A, Koay EJ. Quantitative imaging to evaluate malignant potential of IPMNs. Oncotarget. e-Pub 2016. PMID: 27588410.
114. Carugo A, Genovese G, Seth S, Nezi L, Rose JL, Bossi D, Cicalese A, Shah PK, Viale A, Pettazzoni PF, Akdemir KC, Bristow CA, Robinson FS, Tepper J, Sanchez N, Gupta S, Estecio MR, Giuliani V, Dellino GI, Riva L, Yao W, Di Francesco ME, Green T, D'Alesio C, Corti D, Kang Y, Jones P, bWang H, Fleming JB, Maitra A, Pelicci PG, Chin L, DePinho RA, Lanfrancone L, Heffernan TP, Draetta GF. In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. Cell Rep 16(1):133-47, 2016. e-Pub 2016. PMID: 27320920.
115. Wang OH, Azizian N, Guo M, Capello M, Deng D, Zang F, Fry J, Katz MH, Fleming JB, Lee JE, Wolff RA, Hanash S, Wang H, Maitra A. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer. PLoS One 11(3):e0152300, 2016. e-Pub 2016. PMID: 27023625.
116. Gingras MC, Covington KR, Chang DK, Donehower LA, Gill AJ, Ittmann MM, Creighton CJ, Johns AL, Shinbrot E, Dewal N, Fisher WE, Genome Initiative APC, Pilarsky C, Grützmann R, Overman MJ, Jamieson NB, Van Buren G, Drummond J, Walker K, Hampton OA, Xi L, Muzny DM, Doddapaneni H, Lee SL, Bellair M, Hu J, Han Y, Dinh HH, Dahdouli M, Samra JS, Bailey P, Waddell N, Pearson JV, Harliwong I, Wang H, Aust D, Oien KA, Hruban RH, Hodges SE, McElhany A, Saengboonmee C, Duthie FR, Grimmond SM, Biankin AV, Wheeler DA, Gibbs RA. Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. Cell Rep 14(4):907-19, 2016. e-Pub 2016. PMID: 26804919.
117. Fischer LK, Katz MH, Lee SM, Liu L, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Roland CL, Fleming JB, Estrella J, Rashid A, Wang H. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy. Histopathology, 2016. e-Pub 2016. PMID: 25945396.
118. Stroehlein JR, Poliak M, Wang H. an unusual presentation of myopathy in celiac disease. Practical Gastroenterology XL(1), 2016. e-Pub 2016.
119. Wang Y, Wang L, Guan S, Cao W, Wang H, Chen Z, Zhao Y, Yu Y, Zhang H, Pang JC, Huang SL, Akiyama Y, Yang Y, Sun W, Xu X, Shi Y, Zhang H, Kim ES, Muscal JA, Lu F, Yang J. Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis. Sci Rep 6:19423, 2016. e-Pub 2016. PMID: 26786851.
120. Raghav K, Mhadgut H, McQuade JL, Lei X, Ross A, Matamoros A, Wang H, Overman MJ, Varadhachary GR. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes. PLoS One 11(5):e0154985, 2016. e-Pub 2016. PMID: 27171493.
121. Chadha AS, Skinner HD, Gunther JR, Munsell MF, Das P, Minsky BD, Delclos ME, Chatterjee D, Wang H, Clemons M, George G, Singh PK, Katz MH, Fleming JB, Javle MM, Wolff RA, Varadhachary GR, Crane CH, Krishnan S. Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer. PLoS One 11(6):e0156910, 2016. e-Pub 2016. PMID: 27336466.
122. Wang M, Topalovski M, Toombs JE, Wright CM, Moore ZR, Boothman DA, Yanagisawa H, Wang H, Witkiewicz A, Castrillon DH, Brekken RA. Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer. Cancer Res 75(23):5058-69, 2015. e-Pub 2015. PMID: 26577699.
123. Liu L, Katz MH, Lee SM, Fischer LK, Prakash L, Parker N, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Maitra A, Fleming JB, Estrella J, Rashid A, Wang H. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. Am J Surg Pathol 39(10):1395-403, 2015. e-Pub 2015. PMID: 26200098.
124. Fogelman D, Sugar EA, Oliver G, Shah N, Klein A, Alewine C, Wang H, Javle M, Shroff R, Wolff RA, Abbruzzese JL, Laheru D, Diaz LA. Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma. Cancer Chemother Pharmacol 76(3):489-98, 2015. e-Pub 2015. PMID: 26126726.
125. Xia M, Overman MJ, Rashid A, Chatterjee D, Wang H, Katz MH, Fleming JB, Lee JE, Varadhachary GR, Wolff RA, Wang H. Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma. Hum Pathol 46(9):1315-22, 2015. e-Pub 2015. PMID: 26165226.
126. Estrella JS, Wang H, Bhosale PR, Evans HL, Abraham SC. Malignant Solitary Fibrous Tumor of the Pancreas. Pancreas 44(6):988-94, 2015. e-Pub 2015. PMID: 26166470.
127. Capello M, Lee M, Wang H, Babel I, Katz MH, Fleming JB, Maitra A, Wang H, Tian W, Taguchi A, Hanash SM. Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma. J Natl Cancer Inst 107(8), 2015. e-Pub 2015. PMID: 26025324.
128. Prakash L, Lee JE, Yao J, Bhosale P, Balachandran A, Wang H, Fleming JB, Katz MH. Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors. J Gastrointest Surg. e-Pub 2015. PMID: 26282850.
129. Schueneman A, Goggins M, Ensor J, Saka B, Neishaboori N, Lee S, Maitra A, Varadhachary G, Rezaee N, Wolfgang C, Adsay V, Wang H, Overman MJ. Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma. Br J Cancer 113(1):64-8, 2015. e-Pub 2015. PMID: 25989273.
130. Roland CL, Yang AD, Katz MH, Chatterjee D, Wang H, Lin H, Vauthey JN, Pisters PW, Varadhachary GR, Wolff RA, Crane CH, Lee JE, Fleming JB. Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer. Ann Surg Oncol 22(4):1168-75, 2015. e-Pub 2015. PMID: 25352267.
131. Arumugam T, Deng D, Bover L, Wang H, Logsdon CD, Ramachandran V. New Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice. Mol Cancer Ther 14(4):941-51, 2015. e-Pub 2015. PMID: 25646014.
132. Pettazzoni P, Viale A, Shah P, Carugo A, Ying H, Wang H, Genovese G, Seth S, Minelli R, Green T, Huang-Hobbs E, Corti D, Sanchez N, Nezi L, Marchesini M, Kapoor A, Yao W, Francesco ME, Petrocchi A, Deem AK, Scott K, Colla S, Mills GB, Fleming JB, Heffernan TP, Jones P, Toniatti C, DePinho RA, Draetta GF. Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer. Cancer Res 75(6):1091-101, 2015. e-Pub 2015. PMID: 25736685.
133. Kang Y, Zhang R, Suzuki R, Li SQ, Roife D, Truty MJ, Chatterjee D, Thomas RM, Cardwell J, Wang Y, Wang H, Katz MH, Fleming JB. Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotype. Lab Invest 95(2):207-22, 2015. e-Pub 2015. PMID: 25485535.
134. Gonzalez-Villasana V, Fuentes-Mattei E, Ivan C, Dalton HJ, Rodriguez-Aguayo C, Fernandez-de Thomas RJ, Aslan B, Del C Monroig P, Velasquez-Torres G, Previs RA, Pradeep S, Kahraman N, Wang H, Kanlikilicer P, Ozpolat B, Calin G, Sood AK, Lopez-Berestein G. Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer. Clin Cancer Res, 2015. e-Pub 2015.
135. Luo Z, Li Y, Wang H, Fleming J, Li M, Kang Y, Zhang R, Li D. Hepatocyte Nuclear Factor 1A (HNF1A) as a Possible Tumor Suppressor in Pancreatic Cancer. PLoS One 10(3):e0121082, 2015. e-Pub 2015. PMID: 25793983.
136. Aslan B, Monroig P, Hsu MC, Pena GA, Rodriguez-Aguayo C, Gonzalez-Villasana V, Rupaimoole R, Nagaraja AS, Mangala S, Han HD, Yuca E, Wu SY, Ivan C, Moss TJ, Ram PT, Wang H, Gol-Chambers A, Ozkayar O, Kanlikilicer P, Fuentes-Mattei E, Kahraman N, Pradeep S, Ozpolat B, Tucker S, Hung MC, Baggerly K, Bartholomeusz G, Calin G, Sood AK, Lopez-Berestein G. The ZNF304-integrin axis protects against anoikis in cancer. Nat Commun 6:7351, 2015. e-Pub 2015. PMID: 26081979.
137. Phan L, Chou PC, Velazquez-Torres G, Samudio I, Parreno K, Huang Y, Tseng C, Vu T, Gully C, Su CH, Wang E, Chen J, Choi HH, Fuentes-Mattei E, Shin JH, Shiang C, Grabiner B, Blonska M, Skerl S, Shao Y, Cody D, Delacerda J, Kingsley C, Webb D, Carlock C, Zhou Z, Hsieh YC, Lee J, Elliott A, Ramirez M, Bankson J, Hazle J, Wang Y, Li L, Weng S, Rizk N, Wen YY, Lin X, Wang H, Wang H, Zhang A, Xia X, Wu Y, Habra M, Yang W, Pusztai L, Yeung SC, Lee MH. The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming. Nat Commun 6:7530, 2015. e-Pub 2015. PMID: 26179207.
138. Li X, Truty MA, Kang Y, Chopin-Laly X, Zhang R, Roife D, Chatterjee D, Lin E, Thomas RM, Wang H, Katz MH, Fleming JB. Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery. Clin Cancer Res 20(24):6529-40, 2014. e-Pub 2014. PMID: 25336691.
139. Chen J, Shin JH, Zhao R, Phan L, Wang H, Xue Y, Post SM, Ho Choi H, Chen JS, Wang E, Zhou Z, Tseng C, Gully C, Velazquez-Torres G, Fuentes-Mattei E, Yeung G, Qiao Y, Chou PC, Su CH, Hsieh YC, Hsu SL, Ohshiro K, Shaikenov T, Wang H, Yeung SC, Lee MH. CSN6 drives carcinogenesis by positively regulating Myc stability. Nat Commun 5:5384, 2014. e-Pub 2014. PMID: 25395170.
140. Gonzalez-Villasana V, Rodriguez-Aguayo C, Arumugam T, Cruz-Monserrate Z, Fuentes-Mattei E, Deng D, Hwang RF, Wang H, Ivan C, Garza RJ, Cohen E, Gao H, Armaiz-Pena GN, Del C Monroig-Bosque P, Philip B, Rashed MH, Aslan B, Erdogan MA, Gutierrez-Puente Y, Ozpolat B, Reuben JM, Sood AK, Logsdon C, Lopez-Berestein G. Bisphosphonates Inhibit Stellate Cell Activity and Enhance Antitumor Effects of Nanoparticle Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma. Mol Cancer Ther 13(11):2583-94, 2014. e-Pub 2014. PMID: 25193509.
141. Koay EJ, Baio FE, Ondari A, Truty MJ, Cristini V, Thomas RM, Chen R, Chatterjee D, Kang Y, Zhang J, Court L, Bhosale PR, Tamm EP, Qayyum A, Crane CH, Javle M, Katz MH, Gottumukkala VN, Rozner MA, Shen H, Lee JE, Wang H, Chen Y, Plunkett W, Abbruzzese JL, Wolff RA, Maitra A, Ferrari M, Varadhachary GR, Fleming JB. Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. Phys Biol 11(6):065002, 2014. e-Pub 2014. PMID: 25427073.
142. Estrella JS, Ma LT, Milton DR, Yao JC, Wang H, Rashid A, Broaddus RR. Expression of Estrogen-Induced Genes and Estrogen Receptor β in Pancreatic Neuroendocrine Tumors: Implications for Targeted Therapy. Pancreas 43(7):996-1002, 2014. e-Pub 2014. PMID: 25058880.
143. Viale A, Pettazzoni P, Lyssiotis CA, Ying H, Sánchez N, Marchesini M, Carugo A, Green T, Seth S, Giuliani V, Kost-Alimova M, Muller F, Colla S, Nezi L, Genovese G, Deem AK, Kapoor A, Yao W, Brunetto E, Kang Y, Yuan M, Asara JM, Wang YA, Heffernan TP, Kimmelman AC, Wang H, Fleming JB, Cantley LC, DePinho RA, Draetta GF. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514(7524):628-32, 2014. e-Pub 2014. PMID: 25119024.
144. Wang H, Estrella JS, Chatterjee D, Katz MH, Rashid A, Wang H, Wolff RA, Varadhachary GR, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB. Hepatobiliary/Pancreas Pathology: SY11-3 PANCREATIC DUCTAL ADENOCARCINOMA: NEOADJUVANT THERAPIES AND PATHOLOGY. Pathology 46 Suppl 2:S25, 2014. e-Pub 2014. PMID: 25188109.
145. Roland CL, Arumugam T, Deng D, Liu SH, Philip B, Gomez S, Burns WR, Ramachandran V, Wang H, Cruz-Monserrate Z, Logsdon CD. Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Res 74(18):5301-10, 2014. e-Pub 2014. PMID: 24928781.
146. Estrella JS, Broaddus RR, Mathews A, Milton DR, Yao JC, Wang H, Rashid A. Progesterone Receptor and PTEN Expression Predict Survival in Patients with Low and Intermediate Grade Pancreatic Neuroendocrine Tumors. Arch Pathol Lab Med 138(8):1027-36, 2014. e-Pub 2014. PMID: 25076292.
147. Wang H, Burnett T, Kono S, Haiman CA, Iwasaki M, Wilkens LR, Loo LW, Van Den Berg D, Kolonel LN, Henderson BE, Keku TO, Sandler RS, Signorello LB, Blot WJ, Newcomb PA, Pande M, Amos CI, West DW, Bézieau S, Berndt SI, Zanke BW, Hsu L, Genetics, Cancer Consortium EOC, Lindor NM, Haile RW, Hopper JL, Jenkins MA, Gallinger S, Casey G, Family Registry CC, Stenzel SL, Schumacher FR, Peters U, Gruber SB, Study CT, Tsugane S, Stram DO, Le Marchand L. Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. Nat Commun 5:4613, 2014. e-Pub 2014. PMID: 25105248.
148. Foo WC, Wang H, Prieto VG, Fleming JB, Abraham SC. Squamoid cystosis of pancreatic ducts: a variant of a newly-described cystic lesion, with evidence for an obstructive etiology. Rare Tumors 6(3):5286, 2014. e-Pub 2014. PMID: 25276318.
149. Kapoor A, Yao W, Ying H, Hua S, Liewen A, Wang Q, Zhong Y, Wu CJ, Sadanandam A, Hu B, Chang Q, Chu GC, Al-Khalil R, Jiang S, Xia H, Fletcher-Sananikone E, Lim C, Horwitz GI, Viale A, Pettazzoni P, Sanchez N, Wang H, Protopopov A, Zhang J, Heffernan T, Johnson RL, Chin L, Wang YA, Draetta G, DePinho RA. Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell 158(1):185-97, 2014. e-Pub 2014. PMID: 24954535.
150. Tzeng CW, Balachandran A, Ahmad M, Lee JE, Krishnan S, Wang H, Crane CH, Wolff RA, Varadhachary GR, Pisters PW, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Serum CA 19-9 Represents a Marker of Response to Neoadjuvant Therapy in Patients with Borderline Resectable Pancreatic Cancer. HPB (Oxford) 16(5):430-8, 2014. e-Pub 2014. PMID: 23991810.
151. Guo R, Overman M, Chatterjee D, Rashid A, Shroff S, Wang H, Katz MH, Fleming JB, Varadhachary GR, Abbruzzese JL, Wang H. Aberrant expression of p53, p21, cyclin D1, and Bcl2 and their clinicopathological correlation in ampullary adenocarcinoma. Hum Pathol 45(5):1015-23, 2014. e-Pub 2014. PMID: 24746206.
152. Wang H, Chen Y, Lin P, Li L, Zhou G, Liu G, Logsdon C, Jin J, Abbruzzese JL, Tan T, Wang H. The CUL7/F-box and WD Repeat Domain Containing 8 (CUL7/Fbxw*) Ubiquitin Ligase Promotes Degradation of Hematopoietic Progenitor Kinase 1. J Biol Chem 289(7):4009-17, 2014. e-Pub 2014. PMID: 24362026.
153. Koay EJ, Truty MJ, Cristini V, Thomas RM, Chen R, Chatterjee D, Kang Y, Bhosale PR, Tamm EP, Crane CH, Javle M, Katz MH, Gottumukkala VN, Rozner MA, Shen H, Lee JE, Wang H, Chen Y, Plunkett W, Abbruzzese JL, Wolff RA, Varadhachary GR, Ferrari M, Fleming JB. Transport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest 124(4):1525-36, 2014. e-Pub 2014. PMID: 24614108.
154. Shroff S, Rashid A, Wang H, Katz MH, Abbruzzese JL, Fleming JB, Wang H. SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. Hum Pathol 45(3):456-63, 2014. e-Pub 2014. PMID: 24418153.
155. Christians KK, Tsai S, Mahmoud A, Ritch P, Thomas JP, Wiebe L, Kelly T, Erickson B, Wang H, Evans DB, George B. Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?. Oncologist 19(3):266-74, 2014. e-Pub 2014. PMID: 24569947.
156. Gong J, Xie J, Bedolla R, Rivas P, Chakravarthy D, Freeman JW, Reddick R, Kopetz S, Peterson A, Wang H, Fischer SM, Kumar AP. Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. Clin Cancer Res 20(5):1259-73, 2014. e-Pub 2014. PMID: 24520096.
157. Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Radiographic Tumor-Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer. J Gastrointest Surg 18(2):269-78; discussion 278, 2014. e-Pub 2014. PMID: 24129826.
158. Estrella JS, Li L, Rashid A, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H. Solid Pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. Am J Surg Pathol 38(2):147-57, 2014. e-Pub 2014. PMID: 24418850.
159. Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MH. Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival. J Gastrointest Surg 18(1):16-24; discussion 24-5, 2014. e-Pub 2014. PMID: 24241967.
160. Kang Y, Ling J, Suzuki R, Roife D, Chopin-Laly X, Truty MJ, Chatterjee D, Wang H, Thomas RM, Katz MH, Chiao PJ, Fleming JB. SMAD4 Regulates Cell Motility through Transcription of N-Cadherin in Human Pancreatic Ductal Epithelium. PLoS One 9(9):e107948, 2014. e-Pub 2014. PMID: 25264609.
161. Ligr M, Wu X, Daniels G, Zhang D, Wang H, Hajdu C, Wang J, Pan R, Pei Z, Zhang L, Melis M, Pincus MR, Saunders JK, Lee P, Xu R. Imbalanced expression of Tif1γ inhibits pancreatic ductal epithelial cell growth. Am J Cancer Res 4(3):196-210, 2014. e-Pub 2014. PMID: 24959375.
162. Chang Z, Ju H, Ling J, Zhuang Z, Li Z, Wang H, Fleming JB, Freeman JW, Yu D, Huang P, Chiao PJ. Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis. PLoS One 9(7):e101452, 2014. e-Pub 2014. PMID: 25029561.
163. Chatterjee D, Katz MH, Rashid A, Estrella JS, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB, Wang H. Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma. Histopathology 63(6):841-51, 2013. e-Pub 2013. PMID: 24111684.
164. Philip B, Roland CL, Daniluk J, Liu Y, Chatterjee D, Gomez SB, Ji B, Huang H, Wang H, Fleming JB, Logsdon CD, Cruz-Monserrate Z. A High-Fat Diet Activates Oncogenic Kras and COX2 to Induce Development of Pancreatic Ductal Adenocarcinoma in Mice. Gastroenterology 145(6):1449-58, 2013. e-Pub 2013. PMID: 23958541.
165. Zenali M, Overman MJ, Rashid A, Broaddus RB, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H. Clinicopathologic Features and Prognosis of Duodenal Adenocarcinoma and Comparison with Ampullary and Pancreatic Ductal Adenocarcinoma. Hum Pathol 44(12):2792-8, 2013. e-Pub 2013. PMID: 24139211.
166. Shroff S, Overman MJ, Rashid A, Shroff RT, Wang H, Chatterjee D, Katz MH, Lee JE, Wolff RA, Abbruzzese JL, Fleming JB, Wang H. The Expression of PTEN is Associated With Improved Prognosis in Patients With Ampullary Adenocarcinoma After Pancreaticoduodenectomy. Arch Pathol Lab Med 137(11):1619-26, 2013. e-Pub 2013. PMID: 24168499.
167. Jun S, Lee S, Kim HC, Ng C, Schneider AM, Ji H, Ying H, Wang H, DePinho RA, Park JI. PAF-Mediated MAPK Signaling Hyperactivation via LAMTOR3 Induces Pancreatic Tumorigenesis. Cell Rep S2211-1247(13):00549-4, 2013. e-Pub 2013. PMID: 24209743.
168. Jiang ZQ, Varadhachary G, Wang X, Kopetz S, Lee JE, Wang H, Shroff R, Katz M, Wolff RA, Fleming J, Overman MJ. A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy. Ann Oncol 24(9):2349-53, 2013. e-Pub 2013. PMID: 23704197.
169. Bilen MA, Kim J, Wang H, Tu SM. Cixutumumab-Associated Pancolitis in a Patient With Prostate Cancer. Clin Genitourin Cancer 11(2):207-10, 2013. e-Pub 2013. PMID: 23083799.
170. Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M, Screening Consortium ICOP. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 62(3):339-47, 2013. e-Pub 2013. PMID: 23135763.
171. Li L, Othman M, Rashid A, Wang H, Li Z, Katz MH, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB, Wang H. Solid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells. Histopathology 62(3):465-71, 2013. e-Pub 2013. PMID: 23134473.
172. Zhang Y, Yang J, Cui X, Chen Y, Zhu VF, Hagan JP, Wang H, Yu X, Hodges SE, Fang J, Chiao PJ, Logsdon CD, Fisher WE, Brunicardi FC, Chen C, Yao Q, Fernandez-Zapico ME, Li M. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. EMBO Mol Med 5(9):1322-34, 2013. e-Pub 2013. PMID: 23857777.
173. Zhao Q, X-Y H, Balachandran A, Wang H. Toxic megacolon and fungal diverticulitis and liver abscess due to Mucor indicus infection in a patient with chronic myelogenous leukemia. American Journal of Clinical Cancer Research Vo1. 1, Article ID 20130200151, 2013. e-Pub 2013.
174. Tzeng CD, Balachandran A, Ahmad M, Fleming JB, Lee JE, Krishnan S, Crane CH, Wolff RA, Varadhachary GR, Pisters PWT, Wang H, Aloia TA, J-N V, Katz MH. Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. HPB (Oxford) 16(5):430-8, 2013. e-Pub 2013. PMID: 23991810.
175. Liu X, Xie H, Wang H, McMahon J, Patil DT, Yerian LM. Multifocal Large Cystic Liver Metastasis of a Sinonasal Tract Ameloblastoma: An Unusual Clinical Presentation. J Med Cases 4(8):544-549, 2013. e-Pub 2013.
176. Bhosale P, Balachandran A, Wang H, Wei W, Hwang RF, Fleming JB, Varadhachary G, Charnsangavej C, Tamm E. CT imaging features of acinar cell carcinoma and its hepatic metastases. Abdom Imaging 28(6):1383-90, 2013. e-Pub 2013. PMID: 23232580.
177. Liu X, Lee JH, Charnsangavej C, Geng M, Wang H. Long Survival after Resection of Small Cell Carcinoma of the Pancreas with Synchronous Adenocarcinoma of the Ampulla of Vater. American Journal of Clinical Cancer Research Vol 1(Article ID 20130200152), 2013. e-Pub 2013.
178. Overman MJ, Zhang J, Kopetz S, Davies M, Z-Q J, Stemke-Hale K, Rümmele P, Pilarsky C, Grützmann R, Hamilton S, Hwang R, Abbruzzese JL, Varadhachary G, Broom B, Wang H. Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome. PLoS One 8(6), 2013. e-Pub 2013. PMID: 23776447.
179. Abd-Elgaliel WR, Cruz-Monserrate Z, Wang H, Logsdon CD, Tung CH. Pancreatic cancer-associated Cathepsin E as a drug activator. J Control Release 167(3):221-7, 2013. e-Pub 2013. PMID: 23422726.
180. Huang H, Liu Y, Daniluk J, Gaiser S, Chu J, Wang H, Li ZS, Logsdon CD, Ji B. Activation of nuclear factor-κB in acinar cells increases the severity of pancreatitis in mice. Gastroenterology 144(1):202-10, 2013. e-Pub 2013. PMID: 23041324.
181. Lewis GH, Wang H, Bellizzi AM, Klein AP, Askin FB, Schwartz LE, Schulick RD, Wolfgang CL, Cameron JL, O'Reilly EM, Yu KH, Hruban RH. Prognosis of Minimally Invasive Carcinoma Arising in Mucinous Cystic Neoplasms of the Pancreas. Am J Surg Pathol 37(4):601-605, 2013. e-Pub 2013. PMID: 23388125.
182. Chang Z, Li Z, Wang X, Kang Y, Yuan Y, Niu J, Wang H, Chatterjee D, Fleming JB, Li M, Abbruzzese JL, Chiao PJ. Deciphering the Mechanisms of Tumorigenesis in Human Pancreatic Ductal Epithelial Cells. Clin Cancer Res 144(1):202-10, 2013. e-Pub 2013. PMID: 23340292.
183. Foo WC, Rashid A, Wang H, Katz MH, Lee JE, Pisters PW, Wolff RA, Abbruzzese JL, Fleming JB, Wang H. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma. Hum Pathol 44(6):1024-30, 2013. e-Pub 2013. PMID: 23260327.
184. Kim MP, Truty MJ, Choi W, Kang Y, Chopin-Lally X, Gallick GE, Wang H, McConkey DJ, Hwang R, Logsdon C, Abbruzzesse J, Fleming JB. Molecular Profiling of Direct Xenograft Tumors Established from Human Pancreatic Adenocarcinoma After Neoadjuvant Therapy. Ann Surg Oncol Suppl 3:S395-403, 2012. e-Pub 2012. PMID: 21701930.
185. Thomas RM, Truty MJ, Fleming JB, Pisters PWT, Lee JE, Rice DC, Hofstetter WL, Wolff RA, Varadhachary GR, Wang H, Katz MHG. Selective Re-Operation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection. J Gastrointest Surg 16(9):1696-704, 2012. e-Pub 2012. PMID: 22644446.
186. G Katz MH, Wang H, Balachandran A, Bhosale P, Crane CH, Wang X, T Pisters PW, Lee JE, Vauthey J, Abdalla EK, Wolff R, Abbruzzese J, Varadhachary G, Chopin-Laly X, Charnsangavej C, Fleming JB. Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer. J Gastrointest Surg 16(1):68-78, 2012. e-Pub 2012. PMID: 22065318.
187. Katz MH, Fleming JB, Bhosale P, Varadhachary G, Lee JE, Wolff R, Wang H, Abbruzzese J, Pisters PW, Vauthey JN, Charnsangavej C, Tamm E, Crane CH, Balachandran A. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer 118(23):5749-56, 2012. e-Pub 2012. PMID: 22605518.
188. Wang Y, Ding Q, Yen CJ, Xia W, Izzo JG, Lang JY, Li CW, Hsu JL, Miller SA, Wang X, Lee DF, Hsu JM, Huo L, Labaff AM, Liu D, Huang TH, Lai CC, Tsai FJ, Chang WC, Chen CH, Wu TT, Buttar NS, Wang KK, Wu Y, Wang H, Ajani J, Hung MC. The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell 21(3):374-87, 2012. e-Pub 2012. PMID: 22439934.
189. Ling J, Kang Y, Zhao R, Xia Q, Lee DF, Chang Z, Li J, Peng B, Fleming JB, Wang H, Liu J, Lemischka IR, Hung MC, Chiao PJ. KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 21(1):105-20, 2012. e-Pub 2012. PMID: 22264792.
190. Katayama H, Wang J, Treekitkarnmongkol W, Kawai H, Sasai K, Zhang H, Wang H, Adams HP, Jiang S, Chakraborty SN, Suzuki F, Arlinghaus RB, Liu J, Mobley JA, Grizzle WE, Wang H, Sen S. Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73. Cancer Cell 21(2):196-211, 2012. e-Pub 2012. PMID: 22340593.
191. Chang DZ, Ma Y, Ji B, Liu Y, Hwu P, Abbruzzese JL, Logsdon C, Wang H. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. J Hematol Oncol 5:15, 2012. e-Pub 2012. PMID: 22475564.
192. Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, Lee JE, Pisters PW, Vauthey JN, Crane C, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome. Cancer 118(12):3182-90, 2012. e-Pub 2012. PMID: 22028089.
193. Daniluk J, Liu Y, Deng D, Chu J, Huang H, Gaiser S, Cruz-Monserrate Z, Wang H, Ji B, Logsdon CD. An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest 122(4):1519-28, 2012. e-Pub 2012. PMID: 22406536.
194. Song S, Ji B, Ramachandran V, Wang H, Hafley M, Logsdon C, Bresalier RS. Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling. PLoS One 7(8):e42699, 2012. e-Pub 2012. PMID: 22900040.
195. Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H. Posttherapy Pathologic Stage and Survival in Patients with Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiation. Cancer 118(1):268-77, 2012. e-Pub 2012. PMID: 21735446.
196. Chatterjee D, Rashid A, Wang H, Katz MH, Wolff RA, Varadhachary GR, Lee JE, Pisters PW, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy. Am J Surg Pathol 36(4):552-9, 2012. e-Pub 2012. PMID: 22301496.
197. Cruz-Monserrate Z, Abd-Elgaliel WR, Grote T, Deng D, Ji B, Arumugam T, Wang H, Tung CH, Logsdon CD. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models. Gut 61(9):1315-22, 2012. e-Pub 2012. PMID: 22068166.
198. Thomas RM, Truty MJ, Nogueras-Gonzalez GM, Fleming JB, Vauthey JN, Pisters PW, Lee JE, Rice DC, Hofstetter WL, Wolff RA, Varadhachary GR, Wang H, Katz MH. Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg 16(9):1696-704, 2012. e-Pub 2012. PMID: 22644446.
199. Lu W, Hu Y, Chen G, Chen Z, Zhang H, Wang F, Feng L, Pelicano H, Wang H, Keating MJ, Liu J, McKeehan W, Wang H, Luo Y, Huang P. Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy. PLoS Biol 10(5):e1001326, 2012. e-Pub 2012. PMID: 22589701.
200. Weng S, Wang H, Chen W, Katz MH, Chatterjee D, Lee JE, Pisters PW, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Overexpression of Protein Phosphatase 4 Correlates with Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev 21(8):1336-43, 2012. e-Pub 2012. PMID: 22665577.
201. Zhao Q, Rashid A, Gong Y, Katz MH, Lee JE, Wolf R, Balachandran A, Varadhachary GR, Pisters PW, Wang H, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. Ann Diagn Pathol 16(1):29-37, 2012. e-Pub 2012. PMID: 22050964.
202. Chatterjee D, Katz MH, Rashid A, Wang H, Iuga AC, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Crane CH, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Perineural and Intra-neural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. Am J Surg Pathol 36(3):409-17, 2012. e-Pub 2012. PMID: 22301497.
203. Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H. Histologic Tumor Involvement of Superior Mesenteric Vein/Portal Vein Predicts Poor Prognosis in Patients with Stage II Pancreatic Adenocarcinoma Treated with Neoadjuvant Chemoradiation. Cancer 118(15):3801-11, 2012. e-Pub 2012. PMID: 22180096.
204. Chang DZ, Ma Y, Ji B, Wang H, Deng D, Liu Y, Abbruzzese JL, Liu YJ, Logsdon CD, Hwu P. Mast Cells in Tumor Microenvironment Promotes the in vivo Growth of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 17(22):7015-23, 2011. e-Pub 2011. PMID: 21976550.
205. Varadhachary GR, Spector Y, Abbruzzese JL, Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S, Macinskas J, Lenzi R, Chajut A, Edmonston TB, Raber MN. Prospective Gene Signature Study Using microRNA to Identify the Tissue of Origin in Patients with Carcinoma of Unknown Primary (CUP). Clin Cancer Res 17(12):4063-70, 2011. e-Pub 2011. PMID: 21531815.
206. Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, Qu C, Zhang F, Chen YT, Lin YL, Lee DF, Jin F, Zhu R, Shaikenov T, Sarbassov D, Sahin A, Wang H, Wang H, Lai CC, Tsai FJ, Lozano G, Lee MH. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J Clin Invest 121(3):851-65, 2011. e-Pub 2011. PMID: 21317535.
207. Su CH, Zhao R, Zhang F, Qu C, Chen B, Feng YH, Phan L, Chen J, Wang H, Wang H, Yeung SC, Lee MH. 14-3-3sigma exerts tumor suppressor activity mediated by regulation of COP1 stability. Cancer Res 71(3):884-94, 2011. e-Pub 2011. PMID: 21135113.
208. Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE. ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma. PLoS One 6(6):e20636, 2011. e-Pub 2011. PMID: 21695188.
209. Arumugam T, Brandt W, Ramachandran V, Moore TT, Wang H, May FE, Westley BR, Hwang RF, Logsdon CD. Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis. Pancreas 40(6):815-22, 2011. e-Pub 2011. PMID: 21747314.
210. Yang Q, Wang H, Cho HY, Jung SJ, Kim KR, Ro JY, Shen SS. Carcinoma of müllerian origin presenting as colorectal cancer: a clinicopathologic study of 13 Cases. Ann Diagn Pathol 15(1):12-8, 2011. e-Pub 2011. PMID: 20970364.
211. Dickson PV, Rich TA, Xing Y, Cote GJ, Wang H, Perrier ND, Evans DB, Lee JE, Grubbs EG. Achieving eugastrinemia in MEN1 patients: Both duodenal inspection and formal lymph node dissection are important. Surgery 150(6):1143-52, 2011. e-Pub 2011. PMID: 22136834.
212. Yang G, Chang B, Yang F, Guo X, Cai KQ, Xiao XS, Wang H, Sen S, Hung MC, Mills GB, Chang S, Multani AS, Mercado-Uribe I, Liu J. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res 16(12):3171-81, 2010. e-Pub 2010. PMID: 20423983.
213. Rubbia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu AX, Brezault C, Soubrane O, Abdalla EK, Vauthey JN, Mentha G, Terris B. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 56(4):430-9, 2010. e-Pub 2010. PMID: 20459550.
214. Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB. Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation. Ann Surg Oncol 17(7):1794-801, 2010. e-Pub 2010. PMID: 20162463.
215. Lee SO, Abdelrahim M, Yoon K, Chintharlapalli S, Papineni S, Kim K, Wang H, Safe S. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res 70(17):6824-36, 2010. e-Pub 2010. PMID: 20660371.
216. Liang JJ, Zhu S, Bruggeman R, Zaino RJ, Evans DB, Fleming JB, Gomez HF, Zander DS, Wang H. High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 19(10):2598-604, 2010. e-Pub 2010. PMID: 20732965.
217. Abadeer RA, Fleming JB, Deavers MT, Rashid A, Evans DB, Wang H. Metastatic adult granulosa cell tumor mimicking a benign pancreatic cyst. Ann Diagn Pathol 14(6):457-60, 2010. e-Pub 2010. PMID: 21074697.
218. Peng B, Ling J, Lee AJ, Wang Z, Chang Z, Jin W, Kang Y, Zhang R, Shim D, Wang H, Fleming JB, Zheng H, Sun SC, Chiao PJ. Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter. Proc Natl Acad Sci U S A 107(34):15193-8, 2010. e-Pub 2010. PMID: 20696914.
219. Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, Corley LJ, Abbruzzese JL, Fleming JB, Evans DB, Wang H. High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res 16(14):3734-42, 2010. e-Pub 2010. PMID: 20628027.
220. Fang X, Gupta N, Shen SS, Tamboli P, Charnsangavej C, Rashid A, Wang H. Intraluminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp. Arch Pathol Lab Med 134(7):1003-9, 2010. e-Pub 2010. PMID: 20586628.
221. Wei D, Wang L, Kanai M, Jia Z, Le X, Li Q, Wang H, Xie K. KLF4a up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology 139(6):2135-45, 2010. e-Pub 2010. PMID: 20727893.
222. Maru DM, Kopetz S, Boonsirikamchai P, Agarwal A, Chun YS, Wang H, Abdalla EK, Kaur H, Charnsangavej C, Vauthey JN, Loyer EM. Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol 34(9):1287-94, 2010. e-Pub 2010. PMID: 20697255.
223. Overman MJ, Pozadzides J, Kopetz S, Wen S, Abbruzzese JL, Wolff RA, Wang H. Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer 102(1):144-50, 2010. e-Pub 2010. PMID: 19935793.
224. Overman MJ, Maru DM, Charnsangavej C, Loyer EM, Wang H, Pathak P, Eng C, Hoff PM, Vauthey JN, Wolff RA, Kopetz S. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol 28(15):2549-55, 2010. e-Pub 2010. PMID: 20406923.
225. Higgins RJ, Dickinson PJ, LeCouteur RA, Bollen AW, Wang H, Wang H, Corely LJ, Moore LM, Zang W, Fuller GN. Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping. J Neurooncol 98(1):49-55, 2010. e-Pub 2010. PMID: 19967449.
226. Song X, Wang H, Logsdon CD, Rashid A, Fleming JB, Abbruzzese JL, Gomez HF, Evans DB, Wang H. Overexpression of receptor tyrosine kinase axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer 117(4):734-43, 2010. e-Pub 2010. PMID: 20922806.
227. Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey DJ, Choi W. Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer. Cancer Res 69(14):5820-8, 2009. e-Pub 2009. PMID: 19584296.
228. Yu W, Liu J, Xiong X, Ai Y, Wang H. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Pathology - Research and Practice 205(10):709-15, 2009. e-Pub 2009. PMID: 19541433.
229. Dong X, Jiao L, Li Y, Evans DB, Wang H, Hess KR, Abbruzzese JL, Li D. Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer. Journal of Clinical Oncology 27(10):1592-9, 2009. e-Pub 2009. PMID: 19237629.
230. Wang H, Song X, Logsdon C, Zhou G, Evans DB, Abbruzzese JL, Hamilton SR, Tan T, Wang H. Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer, 2009. e-Pub 2009. PMID: 19141650.
231. Katz MHG, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PWT, Evans DB. Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma. Ann Surg Oncol 16(4):836-47, 2009. e-Pub 2009. PMID: 19194760.
232. Wang H, Song X, Logsdon C, Zhou G, Evans DB, Abbruzzese JL, Hamilton SR, T-H T, Wang H. Proteasome mediated degradation and the functions of hematopoietic progenitor kinase-1 in pancreatic cancer. Cancer Research 69(3):1063-70, 2009. e-Pub 2009. PMID: 19141650.
233. Kim MP, Fleming JB, Wang H, Abbruzzese JL, and Gallick GE. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nature Protocols 4(11):1670-80, 2009. e-Pub 2009. PMID: 19876027.
234. Ji B, Tsou L, Wang H, Gaiser S, Chang DZ, Daniluk J, Bi Y, Grote T, Longnecker DS, Logsdon CD. Ras activity levels control the development of pancreatic diseases. Gastroenterology 137(3):1072-82, 2009. e-Pub 2009. PMID: 19501586.
235. Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Kondo S, Wang H, Wang H, Yeung SC, Lee MH. Hypoxia-mediated upregulation of Pim-1 contributes to solid tumor formation. Am J Pathol 175(1):400-11, 2009. e-Pub 2009.
236. Liang JJ, Wang H, Rashid A, T-T W, Cleary KR, Hamilton SR, Evans DB, Hwang RF, Gomez HF, Tan TH, Zhou GS, Abbruzzese JL, Wang H. Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 20(2):286A, 2008. e-Pub 2008. PMID: 18981001.
237. DGrd B, Kishi Y, Maru DM, Kopetz S, Overman M, Folgelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Clover K, Wolff RA, Curley SA, Abdalla EK, J-N V. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. Journal of Clinical Oncology 26(33):5344-51, 2008. e-Pub 2008. PMID: 18936472.
238. Ramachandran V, Arumugam T, Wang H, and Logsdon CD. Anterior gradient 2 (AGR2) is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Research 68(19):7811-8, 2008. e-Pub 2008. PMID: 18829536.
239. Wei Y, Xia W, Zhang Z, Liu J, Wang H, Adsay NV, Albarracin C, Yu D, Abbruzzese JL, Mills GB, Jr BR, Hortobagyi GN, M-C H. Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian and pancreatic cancers. Mol Carcinog 47(9):701-6, 2008. e-Pub 2008. PMID: 18176935.
240. Tong Z, Kunnumakkara AB, Wang H, Matsuo Y, Diagaradjane P, Harikumar KB, Ramachandran V, Sung B, Chakraborty A, Bresalier RS, Logsdon C, Aggarwal BB, Krishnan S, Guha S. Neutrophil gelatinase-associated lipocalin: A novel suppressor of invasion and angiogenesis in pancreatic cancer, 99th American Association for Cancer Research (AACR) Annual Meeting, April 2008. San Diego, CA. Cancer Res 68(15):6100-8, 2008. e-Pub 2008. PMID: 18676832.
241. Tong Z, Kunnumakkara A, Wang H, Matsuo Y, Diagaradjane P, Harikumar K, Ramachandran V, Sung B, Chakraborty A, Bresalier R, Logsdon C, Aggarwal B, Krishnan S, Guha S. Neutrophil Gelatinase-Associated Lipocalin: A Novel Suppressor of Invasion and Angiogenesis in Pancreatic Cancer. Cancer Research 68(15):6100-8, 2008. e-Pub 2008. PMID: 18676832.
242. Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, and Wolff RA. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. Journal of Clinical Oncology 26(21):3496-502, 2008. e-Pub 2008. PMID: 18640930.
243. Miller DV, Wang H, Wang H, Fealey ME, Tazelaar HD. Beta-catenin mutations do not contribute to cardiac fibroma pathogenesis. Pediatr Dev Pathol 11(4):291-4, 2008. e-Pub 2008. PMID: 18078366.
244. Abraham SC, Wang H, Wang KK, T-T W. Paget's Cells in the Esophagus: Assessment of Their Histopathologic Features and Near-Universal Association with Underlying Esophageal Adenocarcinoma. Am J of Surg Pathol 32(7):1068-74, 2008. e-Pub 2008. PMID: 18496141.
245. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. Journal of Clinical Oncology 26(21):3487-95, 2008. e-Pub 2008. PMID: 18640929.
246. Wang H, Arun BK, Wang H, Fuller GN, Zhang W, Middleton LP, and Sahin A. IGFBP2 and IGFBP5 overexpression is associated to metastasis in T1 breast carcinomas. The Breast Journal 14(3):261-7, 2008. e-Pub 2008. PMID: 18373644.
247. Li J, Wang H, Fuller GN, May S, Wang H. Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas. J Neurooncol 88(1):11-7, 2008. e-Pub 2008. PMID: 18246408.
248. Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PW, Tamm EP, Fleming JB, Abbruzzese JL, Evans DB. Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol 15(5):1356-66, 2008. e-Pub 2008. PMID: 18256882.
249. Verma A, Guha S, Wang H, Fok JY, Koul D, Abbruzzese J, and Mehta K. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clin Cancer Res 14(7):1997-2005, 2008. e-Pub 2008. PMID: 18381937.
250. Baker AF, Koh MY, Williams RR, James B, Wang H, Tate WR, Gallegos A, Von Hoff DD, Han H, Powis G. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer. Pancreas 36(2):178-86, 2008. e-Pub 2008. PMID: 18376310.
251. Phillips KA, Parikh NU, Evans DB, Fisher WE, Adeniran AJ, Wang H, Gallick GE. Tyrosine kinase Src is overexpressed in pancreatitis and pancreatic adenocarcinoma tissue. Journal of Surgical Research:386-387, 2008. e-Pub 2008.
252. Lim SJ, Feig BW, Wang H, Hunt KK, Rodriguez-Bigas MA, Skibber JS, Ellis V, Cleary K, and Chang GJ. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer (60th Annual Best Clinical Paper Award, the Society of Surgical Oncology, 2007). Ann Surg Oncol 15(1):46-51, 2008. e-Pub 2008. PMID: 17985187.
253. DGrd B, Ramirez PT, Wang H, Fleming JB. Distal pancreatectomy for isolated metastasis of endometrial carcinoma to the pancreas. J Pancreas 9(1):56-60, 2008. e-Pub 2008. PMID: 18182745.
254. Liang JJ, Wang H, Rashid A, T-H T, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H. Expression of MAP4K4 is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 14(21):7043-9, 2008. e-Pub 2008. PMID: 18981001.
255. Dallas NA, Gray MJ, Xia L, Fan F, Gnd VB, Gaur P, Samuel S, Lim SJ, Arumugam T, Ramachandran V, Wang H, Ellis LM. Neuropilin-2-Mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clinical Cancer Research 14(24):8052-60, 2008. e-Pub 2008.
256. Sanchez AA, T-T W, Prieto VG, Rashid A, and Wang H. Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases. Arch Path Lab Med 132(10):1623-29, 2008. e-Pub 2008. PMID: 18834221.
257. Yuan P, Wang L, Wei D, Zhang J, Jia Z, Li Q, Le X, Wang H, Yao J, Xie K. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin A correlates directly with a potent antiangiogenic effects on human pancreatic cancer. Cancer 110(12):2682-90, 2007. e-Pub 2007. PMID: 17973266.
258. Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, Chang DZ, Curley SA, Aballa EK, Ellis LM, Vauthey JN. Bevacizumab Increases the Pathological Response and Reduces the Hepatic Injury in Patients Treated with Oxaliplatin-based Chemotherapy for Colorectal Liver Metastases. Cancer 110(12):2761-7, 2007. e-Pub 2007.
259. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, J-N V, Abdalla EK, Lee JE, Pisters PWT, and Evans DB. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246(1):52-60, 2007. e-Pub 2007. PMID: 17592291.
260. Tseng JF, Pisters PW, Lee JE, Wang H, Gomez HF, Sun CC, Evans DB. The learning curve in pancreatic surgery. Surgery 141(5):694-701, 2007. e-Pub 2007. PMID: 17511115.
261. Baruch AC, Wang H, Staerkel GA, Evans DB, Hwang RF, Krishnamurthy S. Immunocytochemical study of the expression of mesothelin in fine-needle aspiration biopsy specimens of pancreatic adenocarcinoma. Diagn Cytopathol 35(3):143-7, 2007. e-Pub 2007. PMID: 17304533.
262. Wang KL, Wu TT, Choi IS, Wang H, Reseetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer 109(4):658-67, 2007. e-Pub 2007. PMID: 17211865.
263. T-T W, Chirieac LR, Abraham SC, Krasinskas A, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG. Excellent interobserver agreement on grading the extent of residual carcinoma following preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: A reliable predictor for patient outcome. Am J of Surg Pathol 31(1):58-64, 2007. e-Pub 2007. PMID: 17197919.
264. Wang H, Silva E. Metastatic well-differentiated mucinous adenocarcinoma consistent with pseudomyxoma peritonei. CAP Check Samples 35(8):89-99, 2007. e-Pub 2007. PMID: 7750935.
265. Verma A, Wang H, Manavathi B, Fok JY, Mann AP, Kumar R, Mehta K. Increased Expression of Tissue Transglutaminase in Pancreatic Ductal Adenocarcinoma and Its Implications in Drug Resistance and Metastasis. Cancer Res 66(21):10525-33, 2006. e-Pub 2006. PMID: 17079475.
266. Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kumar R, Aggarwal BB, Mehta K. Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor kB in cancer cells: Delineation of a novel pathway. Cancer Res 66(17):8788-95, 2006. e-Pub 2006.
267. Wang H, Rosen DG, Wang H, Fuller GN, Zhang W, Liu J. Insulin-like growth factor binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Mod Pathol 19(9):1149-56, 2006. e-Pub 2006. PMID: 16729015.
268. Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Expression of Annexin A1 in Esophageal and Esophagogastric Junction Adenocarcinomas: Association with Poor Outcome. Clin Cancer Res 12(15):4598-604, 2006. e-Pub 2006. PMID: 16899607.
269. Wang H, Wang H, Zhang W, Fuller GN. Overexpression of IGFBP5, but not IGFBP3 correlates with the histologic grade of human diffuse glioma: A tissue microarray and immunohistochemical study. Technol Cancer Res Treat 5(3):195-9, 2006. e-Pub 2006. PMID: 16700616.
270. Wang H, Wang H, Zhang W, Fuller GN. Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study. Technol Cancer Res Treat 5(3):195-9, 2006. e-Pub 2006. PMID: 16700616.
271. Mullen JT, Wang H, Yao JC, Lee JH, Perrier ND, Pisters PWT, Lee JE, and Evans DB. Carcinoid tumors of the duodenum. Surgery 138(6):871-8, 2005. e-Pub 2005. PMID: 16360380.
272. E-J L, Mircean C, Shmulevich I, Wang H, Liu J, Niemisto A, Kavanagh JJ, J-H L, and Zhang W. Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer 4(7), 2005. e-Pub 2005. PMID: 15686601.
273. Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Clin Cancer Res 11(1):267-72, 2005. e-Pub 2005. PMID: 15671555.
274. Wang H, Wang H, Zhang W, Huang H, Liao W, and Fuller G N. Analysis of the activation status of Akt, NFkB and Stat3 in human diffuse gliomas. Laboratory Investigation 84(8):941-51, 2004. e-Pub 2004. PMID: 15184909.
275. Hao X, Sun B, Hu L, Lahdesmaki H, Dunmire V, Feng Y, Zhang SW, Wang H, Wu C, Wang H, Fuller GN, Symmans WF, Shmulevich I, Zhang W. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 100(6):1110-22, 2004. e-Pub 2004. PMID: 15022276.
276. Wang H, Shen SS, Wang H, Diwan AH, Zhang W, Fuller GN, Prieto VG. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions. J Cutan Pathol 30(10):599-605, 2003. e-Pub 2003. PMID: 14744083.
277. Wang H, Wang H, Shen W, Huang H, Hu L, Ramdas L, Zhou Y, Liao WSL, Fuller GN, Zhang W. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion enhancing genes. Cancer Research 63:4315-4321, 2003. e-Pub 2003. PMID: 12907597.
278. Wang H, Actor JK, Indrigo J, Olsen M, Dasgupta A. Asian and Siberian ginseng as a potential modulator of immune function: an in vitro cytokine study using mouse macrophages. (Paul E. Strandjord Young Investigator Award, 6/2006). Clin Chim Acta 327:123-8, 2003. e-Pub 2003. PMID: 12482627.
279. Fuller CE, Wang H, Zhang W, Fuller GN, Perry A. High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH). J Neuropathol Exp Neurol 61(12):1078-84, 2002. e-Pub 2002. PMID: 12484570.
280. Casella R, Nudell D, Cozzolino D, Wang H, Lipshultz LI. Primary testicular amyloidosis mimicking tumor in a cryptorchid testis. Urology 59(3):445, 2002. e-Pub 2002. PMID: 11880098.
281. Wang H, Napoli KL, Strobel HW. Cytochrome P450 3A9 catalyzes the metabolism of progesterone and other steroid hormones. Mol Cell Biochem 213(1-2):127-35, 2000. e-Pub 2000. PMID: 11129951.
282. Rowlands JC, Wang H, Hakkak R, Ronis MJ, Strobel HW, Badger TM. Chronic intragastric infusion of ethanol-containing diets induces CYP3A9 while decreasing CYP3A2 in male rats. J Pharmacol Exp Ther 295:747-52, 2000. e-Pub 2000. PMID: 11046114.
283. Kelly PA, Wang H, Napoli KL, Kahan BD, Strobel HW. Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4. Eur J Drug Metab Pharmacokinet 24(4):321-8, 1999. e-Pub 1999. PMID: 10892895.
284. Wang H, Strobel HW. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Arch Biochem Biophys 344(2):365-72, 1997. e-Pub 1997. PMID: 9264551.
285. Wang H, Kawashima H, Strobel HW. cDNA cloning of a novel CYP3A from rat brain. Biochem Biophys Res Commun 221(1):157-62, 1996. e-Pub 1996. PMID: 8660328.
286. Wang S, Zhang X, Li H, Song S, Luo J, Yang Y, and Wang H. Health effect and economic loss resulting from the environment pollution caused by small electroplating plants. Journal of Hygiene Research 21:38-42, 1992. e-Pub 1992.
287. Xu F, Wang H, and Cao Z. Research on economic analysis and strategy to the effect of the environment pollution of township industries on human health. Journal of Hygiene Research 21:1-23, 1992. e-Pub 1992.
288. Tao Y, Wang H, Fu Y, Yin C, and Xu F. Epidemiological studies on the effect of drinking natural mineral water on human health in Wen Tang. Journal of Environment and Health 9(3):101-3, 1992. e-Pub 1992.
289. Chen X, Lu Y, Lin P, Cang G, Wu C, Gan Y, Sun R, Wu X, and Wang H. Health effect and economic loss resulting from the environment pollution caused by township printing and dyeing mills. Journal of Hygiene Research 21:24-27, 1992. e-Pub 1992.
290. Chen X, Lin P, Lu Y, Cang G, Wu C, Guo R, Zhao Y, Wu X, and Wang H. Health effect and economic loss resulting from the environment pollution caused by small township smelteries of lead. Journal of Hygiene Research 21:28-33, 1992. e-Pub 1992.
291. Tao Y, Wang H, Liu J, Tan Y, and Li W. Utilization of geothermal water and its effect on human health. Journal of Hygiene Research 21(1):21-3, 1992. e-Pub 1992.
292. Zhao D, Yang Z, Wang H, Cao Z. Studies on the environment pollution caused by township cement plants: its health effect, economic analysis and preventive strategies. Journal of Hygiene Research 21:68-71, 1992. e-Pub 1992.
293. Zhao D, Yang Z, Wang H, and Cao Z. Studies on the environment pollution caused by township asphalt felt plants: its health effect, economic analysis and preventive strategies. Journal of Hygiene Research 21:65-68, 1992. e-Pub 1992.
294. Fu Y, Wu X, Cao Z, Wang H, and Yin C. The effect of air pollution caused by the sulfur-smelting with local methods on the health of school children. China Public Health 8(11):487-8, 1992. e-Pub 1992.
295. Qin Y, Guo R, Yin X, Song X, Wu Z, Shen S, Wang H, and Li S. Studies on the subchronic toxicity of dimethyl fumarate. Journal of Hygiene Research 20(2):23-25, 1991. e-Pub 1991.
296. Yin C, Wang H. A method for the determination of SIgA in saliva. Journal of Hygiene Research 19(6):22-24, 1990. e-Pub 1990.
297. Li S, Liu J, Tan Y, Fu J, Yin C, Wang H, and Xu F. Studies on health protection zone around large-scale poultry farms. China Public Health 6(9):397-397, 1990. e-Pub 1990.
298. Li S, Liu J, Tan Y, Fu J, Yin C, Wang H, Wang X, Shen S, Li J, Song X, and Xu F. Investigation on the status of air pollution around poultry farms. China Public Health 6(1):7-8, 1990. e-Pub 1990.
299. Wang H, Yin C, Fu Y, and Xu F. Sulphur-smelting with local methods of rural industries impacts on the level of SIgA in school children saliva. Chinese Journal of Public Health 8(6):378-379, 1990. e-Pub 1990.
300. Li G, Xu Z, Tan Y, Wang H. Smoking and lung cancer in seven cities of Liaoning Province. Journal of Environment and Health 6(5):1-4, 1989. e-Pub 1989.

Invited Articles

1. Luchini, C, Wang, H. Familial Versus Nonfamilial Origin of Acinar Cystic Transformation of the Pancreas. Pancreas 53(3):E298-E299, 2024. e-Pub 2024. PMID: 38335039.
2. Taherian M, Chatterjee D, Wang H. Immune Checkpoint Inhibitor-Induced Hepatic Injury: A Clinicopathologic Review. J Clin Transl Pathol 2(3):83-90, 2022. e-Pub 2022. PMID: 36618338.
3. Taherian M, Wang H, Wang H. Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers. Cells 11(19), 2022. e-Pub 2022. PMID: 36231030.
4. Lai J, Wang HL, Zhang X, Wang H, Liu X. Pathologic Diagnosis of Nonalcoholic Fatty Liver Disease. Arch Pathol Lab Med 146(8):940-946, 2022. e-Pub 2022. PMID: 34871361.
5. Taherian M, Wang H. Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review. Chin Clin Oncol 11(3), 2022. e-Pub 2022. PMID: 35726190.
6. Nagaria TS, Wang H, Wang H. Predictive molecular markers in the era of immunotherapy. Journal of Pancreatology 3(3), 2020. e-Pub 2020.
7. Nagaria TS, Wang H, Chatterjee D, Wang H. Pathology of Treated Pancreatic Ductal Adenocarcinoma and its Clinical Implications. Arch Path Lab Med 144(7):838-845, 2020. e-Pub 2020. PMID: 32023088.
8. Nagaria TS, Wang H. Modification of the 8th AJCC staging system of pancreatic ductal adenocarcinoma. Hepatobiliary Surgical Nutr 9(1):95-97, 2020. e-Pub 2020.
9. Ma Y, Wang H, Yang Y, Logsdon CD, Ullrich SE, Hwu P, Maitra A, Yee C. Recent Advancements in Pancreatic Cancer Immunotherapy. Cancer Research Frontiers 2(2):252-276, 2016. e-Pub 2016.
10. Wang H, Maitra A, Wang H. The emerging roles of F-box proteins in pancreatic tumorigenesis. Semin Cancer Biol 36:88-94, 2016. e-Pub 2016. PMID: 26384530.
11. Wang H, Maitra A, Wang H. Obesity, Intrapancreatic Fatty Infiltration, and Pancreatic Cancer. Clin Cancer Res 21(15):3369-71, 2015. e-Pub 2015. PMID: 25995340.
12. Dhingra S, Wang H. Non-neoplastic Signet Ring Cell Change in Gastrointestinal and Biliary Tract: A Pitfall for Overdiagnosis. Ann Diagn Pathol 15(6):490-6, 2011. e-Pub 2011. PMID: 22082777.
13. Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, Lee JH, Evans DB, Fleming JB. Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. J Am Coll Surg 207(1):106-120, 2008. e-Pub 2008. PMID: 18589369.
14. Akkiprik M, Feng Y, Wang H, Chen K, Hu L, Sahin A, Krishnamurthy S, Ozer A, Hao X, Zhang W. Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer. Breast Cancer Res 10(4):212, 2008. e-Pub 2008. PMID: 18710598.
15. Mortenson MM, Katz MH, Tamm EP, Bhutani MS, Wang H, Evans DB, Fleming JB. Current diagnosis and management of unusual pancreatic tumors. American Journal of Surgery 196(1):100-113, 2008. e-Pub 2008.
16. Varadhachary GR, Tamm EP, Abbruzzese JL, Crane CH, Wang H, Lee JE, Pisters PWT, Evans DB, Wolff RA. Borderline resectable pancreatic Cancer: definitions, management, and the role of preoperative therapy. Ann Surg Oncol 13(8):1035-46, 2006. e-Pub 2006. PMID: 16865597.
17. Wang H, Medeiros LJ, Jones D. Subcutaneous panniculitis-like T-cell lymphoma. Clin Lymphoma 3(3):181-3, 2002. e-Pub 2002. PMID: 12521397.
18. Wang H, Wang H, Zhang W, Fuller GN. Tissue microarrays: applications in neuropathology research, diagnosis, and education. Brain Pathol 12(1):95-107, 2002. e-Pub 2002. PMID: 11770905.
19. Strobel HW, Geng J, Kawashima H, Wang H. Cytochrome P450-dependent biotransformation of drugs and other xenobiotic substrates in neural tissue. Drug Metab Rev 29(4):1079-105, 1997. e-Pub 1997. PMID: 9421686.
20. Strobel HW, Kawashima H, Geng J, Sequeira D, Bergh A, Hodgson AV, Wang H, Shen S. Expression of multiple forms of brain cytochrome P450. Toxicol Lett 82-83:639-43, 1995. e-Pub 1995. PMID: 8597121.

Editorials

1. Chang, Z, Li, Z, Wang, X, Kang, Y, Yuan, Y, Niu, J, Wang, H, Chatterjee, D, Fleming, JB, Li, M, Abbruzzese, JL, Chiao, PJ. Editor's Note. Clinical Cancer Research 30(23):5495, 2024. PMID: 39618198.
2. Wang, H, Basturk, O. Clonal Evolution of Pancreatobiliary Neoplasms. Archives of pathology & laboratory medicine 148(9):973-974, 2024. PMID: 39186616.
3. Yin F, Wang H. Rare Entities and Emerging Issues in Gastrointestinal and Liver Pathology. J Clin Transl Pathol 2(3):67-68, 2022.

Abstracts

1. Taherian M, Waters R, Foo WC, Maru D, Abraham SC, Rashid A, Wang H, Wei D, Taggart MW, Chatterjee D. High-Grade Pancreatic Neuroendocrine Neoplasms: Interobserver Diagnostic Accuracy and Relationship with Clinicopathological and Molecular Characteristics. 15th Annual Multidisciplinary NET Medical Symposium NANETS, 2022. e-Pub 2022.
2. Sohn AJ, Katz MH, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CWD, Lee JE Ikoma N, Rashid A, Wolff RA, Zhao Z, Koay EJ, Maitra A, Wang H. Integrated Pathologic Score Effectively Stratifies Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant therapy and Pancreaticoduodenectomy. USCAP 111th Annual Meeting, 2022. e-Pub 2022.
3. Tong YT, Lai Z, Katz MH, Prakash LR, Wang H, Chatterjee D, Kim M, Tzeng CWD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Maitra A, Wang H. Pathologic prognosticators for patients with pancreatic ductal adenocarcinoma who received neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy. USCAP 111th Annual Meeting, 2022. e-Pub 2022.
4. Taherian M, Waters R, Foo WC, Maru D, Abraham SC, Rashid A, Wang H, Wei D, Taggart MW, Chatterjee D. Blinded Histologic Review to Classify Grade 3 Pancreatic Epithelial Neuroendocrine Neoplasms Shows Only Slight Correlation Among Experienced Gastrointestinal Pathologists. USCAP 111th Annual Meeting, 2022. e-Pub 2022.
5. Sun L, Sohn AJ, Katz MHG, Prakash LR, Wang H, Kim M, Tzeng CWD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Maitra A, Wang H. A Single Center Clinicopathological Study of Comparison of Pancreatic Acinar Cell Carcinoma And Its Mixed Differentiations. USCAP 111th Annual Meeting, 2022. e-Pub 2022.
6. Wang H, Moniruzzaman R, Ji B, Li L, Maitra A, Wang H. Hematopoietic Progenitor Kinase 1 is a Key Regulator for Ras Activity in Early Pancreatic Carcinogenesis. American Pancreas Association 2021 Annual Meeting, 2021. e-Pub 2021.
7. Tong YT, Wang H, Wei D, Prakash LR, Kim M, Tzeng CWD, Lee JE, Rashid A, Koay EJ, Wolff RA, Maitra A, Katz MH, Wang H. GRP78 expression and prognostic significance in treated and treatment-naive patients with pancreatic ductal carcinoma. USCAP 110th Annual Meeting (Virtual), 2021. e-Pub 2021.
8. Wei D, Zaid MZ, Katz MH, Prakash LR, Kim M, Tzeng CWD, Lee JE, Agrawal A, Rashid A, Wang H, Varadhachary G, Wolff RA, Tamm EP, Bhosale PR, Maitra A, Koay EJ, Wang H. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. USCAP 110th Annual Meeting (Virtual), 2021. e-Pub 2021.
9. Bhosale P, Morani AC, Yano M, Morani AC, Lall C, Verma S, Itani M, Gopireddy DR, Iravani A, Saleh M, Francis IR, Sharbidre KG, Rovira JL, Galgano S, Javadi S, Millet J, Roda M, Sharma S, Halperin D, Katz M, Tzeng CWD, Bergsland E, Kunz P, Bhutani MS, Frumovitz M, Wang H, Das K, Chatterjee D, Trikalinos N, Kim H, Hammill C, Maxwell J. Neuroendocrine neoplasm DFP report. Abdominal Radiology, 2021. e-Pub 2021.
10. DePeri TP, Evans KW, Tzeng CWD, Kwong L, Kahle MP, Zheng X, Li D, Cao HST, Vu T, Kim S, Su F, Kirby B, Wathoo C, Raso G, Rizvi Y, Wang H, Jang P, Shaw K, Yap T, Javie M, Rodon J, Meric-Bernstam F. The MD Anderson patient-derived xenograft series for modeling precision oncology in biliary tract cancers. American Association for Cancer Research Meeting (AACR), 2021. e-Pub 2021.
11. Wang H, Song X, Akasaka H, Abbasgholizadeh R, Shin J, Logsdon CD, Maitra A, Bean AJ, Wang H. Novel mechanism involved in the regulation of oncogenic Axl receptor tyrosine kinase in cancer. Annual Meeting of the American Association for Cancer Research 2020 80(16), 2020. e-Pub 2020.
12. Wang H, Song X, Akasaka H, Abbasgholizadeh R, Shin JH, Logsdon CD, Maitra A, Bean AJ, Wang H. Novel mechanism involved in the regulation of oncogenic Axl receptor tyrosine kinase in cancer [abstract]. Proceedings of the Annual Meeting of the American Association for Cancer Research, 2020. e-Pub 2020.
13. Dey P, Li J, Zhang J, Wang H, Liao W, Bernard VP, Genovese G, Maitra A, Strom A, DePinho RA. CD4 T cells mediated protumorigenic pathway in pancreatic cancer. AACR Special Conference on Pancreatic Cancer: Advances in Science and Clinical Care. e-Pub 2019.
14. Carstens JL, Sampaio PC, Barua S, Wang H, Burks JK, Rao A, LeBieu VS, Kalluri R. Intratumoral T-cell distribution in murine and patient pancreatic cancer correlates with tissue heterogeneity and survival. AACR Special Conference on Pancreatic Cancer: Advances in Science and Clinical Care, 2019. e-Pub 2019.
15. Hui L, Rashid A, Foo WC, Katz M, Fleming J, Tamm E, Wang H. Significance of T1a and T1b Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas. USCAP 106th Annual Meeting, 2018. e-Pub 2018.
16. Patel V, Samdani R, Abraham S, Estrella JS, Taggart MW, Tan D, Wang H, Rashid A, Foo WC, Maru D. Clinicopathologic Predictors of Long-Term Responders to Trastuzumab based therapy in Stage IV Esophageal Adenocarcinoma. USCAP 107th Annual Meeting, 2018. e-Pub 2018.
17. Wang M, Estrella JS, Katz MH, Lee JE, Maitra A, Wolff RA, Varadhachary GR, Wang H. Expression of epithelial to mesenchymal transition markers in treated pancreatic duct adenocarcinoma. USCAP 107th Annual Meeting, 2018. e-Pub 2018.
18. Hui L, Rashid A, Foo WC, Katz M, Fleming J, Tamm E, Wang H. Significance of T1a and T1b Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas. USCAP 106th Annual Meeting, 2017. e-Pub 2017.
19. Chatterjee D, Katz M, Foo WC, Sundar M, Wang H, Varadhachary G, Wolff R, Lee J, Maitra A, Fleming J, Rashid A, Wang H. Prognostic Significance of New AJCC Tumor (T) Stage in Patients with Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy. Accepted for presentation at the USCAP 106th Annual Meeting which will be held in San Antonio, TX , March 4-10, 2017, 2017. e-Pub 2017.
20. Xia M, Overman M, Rashid A, Wang H, Katz MH, Fleming JB, Wolfe RA, Wang H. Expression and Clinical Significance of EGFR, IGF-1R and HER-2 in Patients with Ampullary Adenocarcinoma. 103rd USCAP Annual Meeting, San Diego, CA, March 1-7, 2014. Modern Pathology 27(Supplement 2):201A, 2014. e-Pub 2014.
21. Liang L, Rashid A, J-J V, Wang H. Clinicopathologic Features of Hepatocellular Carcinoma with Prominent Lymphoid Stroma. 103rd USCAP Annual Meeting, San Diego CA, March 1-7, 2014. Modern Pathology 27(Supplement 2):424A, 2014. e-Pub 2014.
22. Weng B, Rashid A, Grubbs E, Lee JE, Wang H. Gastrinomas Associated with Multiple Endocrine Neoplasia Type 1 (MEN 1) Syndrome: A Clinicopathologic Study of 14 cases. 103rd USCAP Annual Meeting, San Diego CA, March 1-7, 2014. Modern Pathology 27(Supplement 2):457A, 2014. e-Pub 2014.
23. Estrella JS, Li L, Rashid A, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H. Solid Pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. 103rd Annual Meeting of United States and Canadian Academy of Pathology, San Diego, CA, March 1-7, 2014. Modern Pathology 27(Supplement 2):448-449A, 2014. e-Pub 2014.
24. Shroff S, Rashid A, Wang H, Katz MH, Lee JE, Abbruzzese JL, Fleming JB, Wang H. SOX9: A novel marker for pancreatic centroacinar cell and ductal cell differentiation. 102nd Annual Meeting, United States & Canadian Academy of Pathology, Baltimore MD, Mar 2-8, 2013. Modern Pathology 26(Supplement 2):431A, 2013. e-Pub 2013.
25. Guo R, Rashid A, Overman M, Wang H, Abbruzzese JL, Wang H. Immunohistochemical Study of Ampullary and Small Bowel Adenocarcinomas. 102nd Annual Meeting, United States & Canadian Academy of Pathology, Baltimore MD, Mar 2-8, 2013. Modern Pathology 26(Supplement 2):152A, 2013. e-Pub 2013.
26. Chatterjee D, Katz MH Rashid A, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Abrruzzese JL, Fleming JB, Wang H. Histologic Changes in Non-Neoplastic Pancreas after Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma. 102nd Annual Meeting of United States and Canadian Academy of Pathology, Baltimore MD, Mar 2-8, 2013. Modern Pathology 26(Supplement 2):423A, 2013. e-Pub 2013.
27. Ma LT, Wang H, Rashid A, Broaddus RR, Estrella JS. Estrogen-Induced Genes Are Expressed in Pancreatic Neuroendocrine Tumors. 102nd Annual Meeting of United States and Canadian Academy of Pathology, Baltimore MD, Mar 2-8, 2013. Modern Pathology 26(Supplement 2):427A-428A, 2013. e-Pub 2013.
28. Zhao Q, Weng S, Foo WC, Estrella JS, Yao JC, Wang H, Wang H, Rashid A. Loss of Expression of DAXX and ATRX in Low-Grade Neuroendocrine Tumors (Carcinoid Tumors) 101st Annual Meeting of United States and Canadian Academy of Pathology, Vancouver BC, Canada, Mar 17-23, 2012. Modern Pathology 25(Supplement 2):187A, 2012. e-Pub 2012.
29. Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, Lee JE, Pisters PWT, J-N V, Crane C, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Histologic Grading the Extent of Residual Carcinoma Following Neoadjuvant Chemoradiation in Pancreatic Ductal Adenocarcinoma: A Predictor for Patient Outcome. 101st Annual Meeting of United States and Canadian Academy of Pathology, Vancouver BC, Canada, Mar 17-23, 2012. Modern Pathology 25(Supplement 2):441A, 2012. e-Pub 2012.
30. Lee L, Ligr M, Wang H, Hajdu C, Pei Z, Xu R. Overexpression of Transcriptional Intermediary Factor 1 Gamma (TIF1γ) and Loss of SMAD4 Are Common Events but Are Not Correlated with Each Other in Pancreatic Ductal Carcinoma. 101st Annual Meeting of United States and Canadian Academy of Pathology, Vancouver BC, Canada, Mar 17-23, 2012. Modern Pathology 25(Supplement 2):446A, 2012. e-Pub 2012.
31. Estrella JS, Broaddus RR, Yao JC, Wang H, Rashid A. Combined Progesterone Receptor and PTEN Expression Predicts Metastasis and Survival in Patients with Pancreatic Neuroendocrine Tumors. 101st Annual Meeting of United States and Canadian Academy of Pathology Vancouver BC, Canada, Mar 17-23, 2012. Modern Pathology 25(Supplement 2):442A, 2012. e-Pub 2012.
32. Zenali MJ, Overman M, Rashid A, Hamilton SR, Broaddus RR, Katz MH, Abbruzzese JL, Fleming JB, Wang H. Clinicopathological Review of 62 Cases of Primary Duodenal Adenocarcinoma. 101st Annual Meeting of United States and Canadian Academy of Pathology, Vancouver BC, Canada, Mar 17-23, 2012. Modern Pathology 25(Supplement 2):187A, 2012. e-Pub 2012.
33. Thomas RM, Truty MJ, Fleming JB, Pisters PW, Lee JE, Rice DC, Hofstetter WL, Wolff RA, Vardhachary GR, Wang H, Katz MH. Selective Re-operation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma following Primary Pancreatic resection. 65th Annual Cancer Symposium of the Society of Surgical Oncology (SSO), Orlando FL, Mar 21-24, 2012. Annals of Surgical Oncology 19(Supplement 1):S160, 2012. e-Pub 2012.
34. Foo WC, Rashid A, Wang H, Hamilton SR, Katz MH, Lee JE, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Loss of PTEN Expression in Pancreatic Ductal Adenocarcinoma Is Associated with Poor Survival. 101st Annual Meeting of United States and Canadian Academy of Pathology, Vancouver BC, Canada, Mar 17-23, 2012. Modern Pathology 25(Supplement 2):442A-443A, 2012. e-Pub 2012.
35. Shroff S, Overman M, Rashid A, Wang H, Shroff R, Hamilton SR, Katz MH, Lee JE, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Loss of PTEN Expression Is Associated with Poor Prognosis in Patients with Ampullary Adenocarcinoma. 101st Annual Meeting of United States and Canadian Academy of Pathology, Vancouver BC, Canada, Mar 17-23, 2012. Modern Pathology 25(Supplement 2):448A, 2012. e-Pub 2012.
36. Lewis GH, Wang H, Fisher W, Schulick R, Wolfgang C, Cameron JL, Hruban RH. Prognosis of minimally invasive adenocarcinoma arising in mucinous cystic neoplasms of the pancreas. 100th Annual Meeting of United States and Canadian Academy of Pathology, San Antonio TX, Feb 26-Mar 4, 2011. Modern Pathology 24(Supplement 1):156A-157A, 2011. e-Pub 2011.
37. Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PWT, Abdalla EK, J-N V, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H. Posttherapy Pathologic Stage and Survival in Patients with Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiation. Modern Pathology 24(Supplement 1):359A, 2011. e-Pub 2011.
38. Zhao Q, Rashid A, Gong Y, Katz MH, Lee JE, Wolf RA, Charnsangavej C, Varadhachary GR, Pisters PXT, Abdalla EK, J-N V, Wang H, Gomez HF, Fleming JB, Abbruzzese JL, Wang H. Pathologic Complete Response Is Associated with Good Prognosis in Patient with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Chemoradiation and Pancreatectomy. 100th Annual Meeting of United States and Canadian Academy of Pathology, San Antonio TX, Feb 26-Mar 4, 2011. Modern Pathology 24(Supplement 1):378A, 2011. e-Pub 2011.
39. Estrella JS, Wang H, Taggart MW, Abraham SC, Rashid A. Immunohistochemical expression of progesterone receptor in neuroendocrine tumors: Expression is present predominantly in low-grade pancreatic endocrine neoplasms. 99th Annual Meeting of United States and Canadian Academy of Pathology, Washing DC, Mar 20-26, 2010. Modern Pathology 23(Supplement 1):353A-354A, 2010. e-Pub 2010.
40. Chen S, Albarracin C, Wang H, Klein K, Sahin A, Wang H. Downregulation of hematopoietic progenitor kinase 1 protein level in ductal carcinoma in situ and invasive ductal carcinoma of breast. 99th Annual Meeting of United States and Canadian Academy of Pathology, Washington DC, Mar 20-26, 2010. Modern Pathology 23(Supplement 1):39A-40A, 2010. e-Pub 2010.
41. Chen S, Overman MJ, Abbruzzese JL, Wolff RA, Wang H. Loss of Cytokeratin 20 Expression in Small Bowel Carcinoma with High Level of Microsatellite Instability. 99th Annual Meeting of the United States and Canadian Academy of Pathology, Washington DC, Mar 20-26, 2010. Modern Pathology 23(Supplement 1):140A, 2010. e-Pub 2010.
42. Agarwal A, Kopetz S, Boonsirikamchai P Chun YS, Wang H, Vauthey JN, Loyer EM, Maru DM. Tumor thickness at the tumor-normal interface (TNI): a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases (HCRM). 99th Annual Meeting of United States and Canadian Academy of Pathology, Washington DC, Mar 20-26, 2010. Modern Pathology 23(Supplement 1):134A, 2010. e-Pub 2010.
43. Othman ML, Rashid A, Abbruzzese JL, Wolff RA, Wang H. Expression of aldehyde dehydrogenase is associated with high-grade histology and poor survival in patients with primary small bowel adenocarcinomas. 99th Annual Meeting of United States and Canadian Academy of Pathology, Washington DC, Mar 20-26, 2010. Modern Pathology 23(Supplement 1):160A, 2010. e-Pub 2010.
44. Liang JJ, Wang H, Bruggeman R, Evans DB, Wang H. High levels of expression of activating transcription factor 2 (ATF2) are associated with worse prognosis in patients with pancreatic ductal adenocarcinoma. 99th Annual Meeting of United States and Canadian Academy of Pathology, Washington DC, Mar 20-26, 2010. Modern Pathology 23(Supplement 1):362A, 2010. e-Pub 2010.
45. Wang H, Yang Q, Cho HY, Jung SJ, Kim KR, Ro JY, Shen SS. Carcinoma of Mullerian origin presenting as colorectal cancer: histologic and immunohistochemical studies of 13 cases. 98 Annual Meeting of United States and Canadian Academy of Pathology, Boston, MA, Mar 7-13,2009. Modern Pathology 22(Supplement 1):152A, 2009. e-Pub 2009.
46. Rubbia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu A, Brezault C, Soubrane O, Abdalla EK, Vauthey JN, Mentha G, Terris B. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are major liver lesions associated with oxaliplatin-based chemotherapy for colorectal liver metastasis and partially prevented by bevacizumab. 98th Annual Meeting of United States and Candian Academy of Pathology, Boston MA, Mar 7-13, 2009. Modern Pathology 22(Supplement 1):320A, 2009. e-Pub 2009.
47. Liang JJ, Zhu S, Bruggeman R, Evans D, Zaino R, Sander D, Wang H. High levels of expression of human stromal cell-derived factor-1 (SDF-1) are associated with worse prognosis in patients with pancreatic ductal adenocarcinoma. 98th Annual Meeting of United States and Canadian Academy of Pathology, Boston MA, Mar 7-13, 2009. Modern Pathology 22(Supplement 1):315A, 2009. e-Pub 2009.
48. Maru DM, Correa AM, Tong Z, Wang H, Wu TT, Corley L, Krishnan S, Ajani JA, Swisher SG, Rashid A, Hofstetter WL, Guha S. Loss of neutrophil gelatinase associated lipocalin (NGAL) expression in esophageal adenocarcinoma (EAC) is associated with higher pathologic stage and poor survival. 98th Annual Meeting of United States and Canadian Academy of Pathology, Boston MA, Mar 7-13, 2009. Modern Pathology 22(Supplement 1):139A, 2009. e-Pub 2009.
49. Fang X, Taggart M, Corley L, Wang H, Wang H, Hamilton SR, Rashid A. Nucleolin expression in colorectal adenocarcinomas: Higher nucleolin expression is associated with better survival in stage III colorectal cancers. 98th Annual Meeting of United States and Canadian Academy of Pathology, Boston MA, Mar 7-13, 2009. Modern Pathology 22(Supplement 1):129A, 2009. e-Pub 2009.
50. Peng L, Rashid A, Evans DB, Varadhachary GR, Lee JE, Fleming JB, Pisters PWT, Abbruzzese JL, Wolff RA, Wang H. Superior mesenteric vein/portal vein invasion is associated with poor survival in patients with stage II pancreatic ductal carcinoma who received pre-operative chemoradiation. 97th Annual Meeting of the United States and Canadian Academy of Pathology, Denver, CO, Mar 1-7, 2008. Modern Pathology 21(Supplement 1):319A, 2008. e-Pub 2008.
51. Taggart MW, Wang H, Maru DM, Tan D, Rashid A. Appendiceal mixed carcinoid-adenocarcinomas share better prognosis associated with goblet cell carcinoid tumors. 97th Annual Meeting of the United States and Canadian Academy of Pathology, Denver CO, Mar 01-07, 2008. Modern Pathology 21(Supplement 1):37A, 2008. e-Pub 2008.
52. Peng L, Liang J, Rashid A, Evans DB, Gomez H, Corley LJ, Abbruzzese JL, Hamilton SR, Wang H. High level of nucleolin expression is associated with better prognosis in patients with stage it pancreatic ductal adenocarcinoma. 97th Annual Meeting of the United States and Canadian Academy of Pathology, Denver CO, Mar 01-07, 2008. Modern Pathology 21(Supplement 1):132A, 2008. e-Pub 2008.
53. Abraham SC, Wang H, Wang KK, Wu TT. Paget cells in the esophagus: Assessment of their histopathologic features and near-universal association with underlying adenocarcinoma. 97th Annual Meeting of the United States and Canadian Academy of Pathology, Denver CO. Modern Pathology 21(Supplement 1):112A, 2008. e-Pub 2008.

Book Chapters

1. Wang H, Samdani R. Neoplasms of Small bowel. In: College of American Pathologists, 2021.
2. Chatterjee D, Wang H. Tumors of Ampulla of Vater. In: College of American Pathologists, 2021.
3. Wang H, Adsay V, He J. Exocrine and endocrine neoplasms of pancreas. In: College of American Pathologists, 2021.
4. Wang H, Adsay V, He J. Exocrine and endocrine neoplasms of pancreas. In: College of American Pathologists, 2021.
5. Asare EA, Wang H, Tamm EP, Mortenson MM, Evans DB, Tsai S. Unusual pancreatic tumors. In: Shackelford's Surgery of the Alimentary Trac. 8th, 2019.
6. Foo WC, Wang H. In: Pathology and Epidemiology of Cancer: Molecular Underpinnings. In: Pathology and Molecular Pathology of Pancreatic Cancer, 2017.
7. Tsai S, Mortenson MM, Wang H, Tamm EP, Evans DB. Unusual pancreatic tumors. In: Shackelford's Surgery of the Alimentary Tract, 7th edition. Elsevier Saunders, 2012.
8. Raut CP, Varadhachary G, Wang H, Tamm EP, Fleming JB, Evans DB. Margin Status Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Implications of R Status. In: Diseases of the Pancreas: Current Surgical Therapy, 1st edition. Springer Verlag, 2008.
9. Amos KD, Kennamer DL, Chanrsangavej C, Wang H, Evans DB. Surgical Treatment of Pancreatic Adenocarcinoma. In: Advanced Therapy in Surgical Oncology. Hamilton: BC Decker Inc, 2008.
10. Varadhachary G, Crane CH, Tamm EP, Wang H, Wolff RA, and Evans DB. Neoadjuvant treatment of pancreatic cancer: borderline resectable disease. In: The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery, 2nd Edition. Wiley-Blackwell, 2008.
11. Mortenson MM, Kennamer DL, Tamm EP, Wang H, and Evans DB. Pancreatic Carcinoma. In: General Surgery: Principles and International Practice, 2nd edition, Bland KI, Büchler MW, Csendes A, et al. (eds). Springer, 2008.
12. Camp ER, Tamm EP, Gomez HF, Wang H, and Evans DB. Unusual pancreatic tumors. In: Shackelford's Surgery of the Alimentary Tract, 6th edition. Saunders, 2006.
13. Ribalta T, Wang H, Fuller GN. Tissue microarrays: applications in neuro-oncology research. In: Genomic and Molecular Neuro-Oncology (Chinese Translation). Tianjin: Science and Technology Translation, 2005.
14. Ribalta T, Wang H, Perry A, Zhang W, Fuller GN. Tissue microarrays: clinical and research applications in CNS tumors. In: Genomic and Molecular Neuro-Oncology. Jones and Bartlett, 2004.
15. Wang H, Chatterjee. Frozen section diagnosis and intra-operative consultation for Pancreaticobiliary tract. In: Manual of Pancreas and Biliary Tract Pathology.
16. Wang H, Chatterjee. Pathology of treated pancreatic ductal adenocarcinoma. In: Manual of Pancreas and Biliary Tract Pathology.

Books (edited and written)

1. Wang HL, Wang H. CAP Manual of Gastrointestinal.
2. Wang H, Adsay V. Manual of Pancreas and Biliary Tract Pathology.

Letters to the Editor

1. Overman M, Wang H, Varadhachary GR. Adjuvant chemotherapy for resected periampullary adenocarcinoma. Author Reply 1855-6. JAMA 308: 1855; author reply 1855-6, 2012.
2. Wang H, Zhao Q. Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with better prognosis. Author Reply. Ann Diagn Pathol 16: 427, 2012.
3. Overman MJ, Wolff RA, Wang H. Reply to comment: Cetuximab in small bowel adenocarinoma (SBA): a new friend?. British Journal of Cancer 103: 1306, 2010.